Cover
Cover - shares | 9 Months Ended | |
Sep. 30, 2023 | Nov. 13, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Sep. 30, 2023 | |
Document Fiscal Period Focus | Q3 | |
Document Fiscal Year Focus | 2023 | |
Current Fiscal Year End Date | --12-31 | |
Entity File Number | 333-150028 | |
Entity Registrant Name | BUNKER HILL MINING CORP. | |
Entity Central Index Key | 0001407583 | |
Entity Tax Identification Number | 32-0196442 | |
Entity Incorporation, State or Country Code | NV | |
Entity Address, Address Line One | 82 Richmond Street East | |
Entity Address, City or Town | Toronto | |
Entity Address, State or Province | ON | |
Entity Address, Country | CA | |
Entity Address, Postal Zip Code | M5C 1P1 | |
City Area Code | (416) | |
Local Phone Number | 477-7771 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 322,619,482 |
Condensed Interim Consolidated
Condensed Interim Consolidated Balance Sheets - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Current assets | ||
Cash | $ 28,360,495 | $ 708,105 |
Restricted cash | 6,476,000 | 6,476,000 |
Accounts receivable and prepaid expenses (note 3) | 685,318 | 556,947 |
Total current assets | 35,521,813 | 7,741,052 |
Non-current assets | ||
Spare parts inventory | 341,004 | 341,004 |
Equipment (note 4) | 664,188 | 551,204 |
Right-of-use asset (note 4) | 143,549 | |
Long term deposit | 249,265 | 269,015 |
Bunker Hill Mine and mining interests (note 5) | 14,693,810 | 15,896,645 |
Process plant (note 4) | 13,550,493 | 8,130,972 |
Total assets | 65,164,122 | 32,929,892 |
Current liabilities | ||
Accounts payable | 1,842,719 | 4,523,502 |
Accrued liabilities | 862,010 | 1,500,164 |
Current portion of lease liability | 23,500 | |
Derivative warrant liability (note 8) | 903,697 | |
Deferred share units liability (note 10) | 719,097 | 573,742 |
Interest payable (note 7) | 579,558 | 1,154,477 |
Promissory notes payable (note 7) | 1,095,253 | 1,500,000 |
Total current liabilities | 5,122,137 | 10,155,582 |
Non-current liabilities | ||
Bridge loan (note 7) | 4,684,446 | |
Series 1 convertible debenture (note 7) | 5,190,551 | 5,537,360 |
Series 2 convertible debenture (note 7) | 12,746,242 | 14,063,525 |
Stream obligation (note 7) | 46,665,044 | |
Royalty convertible debenture (note 7) | 10,285,777 | |
Environmental protection agency cost recovery liability, net of discount (note 6) | 9,132,953 | 7,941,466 |
Deferred tax liability (note 12) | 2,842,067 | |
Derivative warrant liabilities (note 8) | 4,657,031 | 6,438,679 |
Total liabilities | 86,356,025 | 59,106,835 |
Shareholders’ Deficiency | ||
Preferred shares, $0.000001 par value, 10,000,000 preferred shares authorized; Nil preferred shares issued and outstanding (note 8) | ||
Common shares, $0.000001 par value, 1,500,000,000 common shares authorized; 317,444,482 and 229,501,661 common shares issued and outstanding, respectively (note 8) | 316 | 228 |
Additional paid-in-capital (note 8) | 57,262,905 | 45,161,513 |
Accumulated other comprehensive income | 756,210 | 253,875 |
Accumulated deficit | (79,211,334) | (71,592,559) |
Total shareholders’ deficiency | (21,191,903) | (26,176,943) |
Total shareholders’ deficiency and liabilities | $ 65,164,122 | $ 32,929,892 |
Condensed Interim Consolidate_2
Condensed Interim Consolidated Balance Sheets (Parenthetical) - $ / shares | Sep. 30, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value | $ 0.000001 | $ 0.000001 |
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, shares issued | ||
Preferred stock, shares outstanding | ||
Common stock, par value | $ 0.000001 | $ 0.000001 |
Common stock, shares authorized | 1,500,000,000 | 1,500,000,000 |
Common stock, shares issued | 317,444,482 | 229,501,661 |
Common stock, shares outstanding | 317,444,482 | 229,501,661 |
Condensed Interim Consolidate_3
Condensed Interim Consolidated Statements of (loss) Income and Comprehensive Income (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Operating expenses | ||||
Operation and administration | $ 1,530,884 | $ 150,910 | $ 4,414,781 | $ 587,514 |
Mine preparation | 2,533,101 | 6,861,403 | ||
Legal and accounting | 443,635 | 210,960 | 1,367,322 | 975,014 |
Consulting and wages | 797,203 | 929,977 | 2,512,080 | 4,867,553 |
Loss from operations | (2,771,722) | (3,824,948) | (8,294,183) | (13,291,484) |
Other income or gain (expense or loss) | ||||
Interest income | 476,397 | 707,530 | ||
Change in derivative liabilities (note 8) | 8,531,630 | 7,315,161 | (488,357) | 18,538,380 |
Gain on FV of debentures (note 7) | 2,450,968 | 1,301,069 | 2,256,437 | 3,041,056 |
Gain on EPA settlement | 8,614,103 | |||
Gain on debt settlement (note 5) | 7,117,420 | |||
Gain on warrant settlement | 214,714 | |||
Interest expense (note 6,7) | (2,293,643) | (1,026,233) | (5,006,692) | (2,143,840) |
Debenture finance costs | (64,054) | (1,230,539) | ||
Finance costs (note 7, 8) | 170,771 | (930,110) | (455,653) | |
Loss on debt modification (note 7) | (99,569) | |||
Loss on debt settlement (note 7) | (491,643) | |||
Other (loss) income | (919) | 1,811 | 23,520 | 26,002 |
(Loss) on foreign exchange | (18,622) | (12,453) | (22,101) | (233,777) |
(Loss) income for the period pre tax | 6,544,860 | 3,690,353 | (5,013,034) | 12,864,248 |
Deferred tax recovery (expense) (note 12) | 903,000 | (2,605,741) | ||
Net (loss) income for the period | 7,447,860 | 3,690,353 | (7,618,775) | 12,864,248 |
Other comprehensive income, net of tax: | ||||
Gain on change in FV on own credit risk | 68,738 | 625,050 | 502,335 | 996,636 |
Other comprehensive income | 68,738 | 625,050 | 502,335 | 996,636 |
Comprehensive (loss) income | 7,516,598 | 4,315,403 | (7,116,440) | 13,860,884 |
Dilutive effect of derivative warrant liabilities | ||||
Diluted net (loss) income and comprehensive (loss) income for the period | $ 7,516,598 | $ 4,315,403 | $ (7,116,440) | $ 13,860,884 |
Net income (loss) per common share – basic | $ 0.02 | $ 0.02 | $ (0.03) | $ 0.07 |
Net income (loss) per common share – fully diluted | $ 0.01 | $ 0.01 | $ (0.03) | $ 0.05 |
Weighted average common shares – basic | 303,974,814 | 219,466,235 | 266,313,125 | 198,364,188 |
Weighted average common shares – fully diluted | 415,044,889 | 318,204,510 | 266,313,125 | 250,681,393 |
Condensed Interim Consolidate_4
Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Operating activities | |||||
Net (loss) income for the period | $ 7,447,860 | $ 3,690,353 | $ (7,618,775) | $ 12,864,248 | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||
Stock-based compensation | 1,131,965 | (300,475) | |||
Depreciation expense | 126,425 | 172,259 | |||
Change in fair value of warrant liability | 488,357 | (18,538,380) | |||
Deferred tax expense | (903,000) | 2,605,741 | |||
Gain on warrant settlement | (214,714) | ||||
Units issued for services | 111,971 | 1,060,858 | |||
Interest expense on lease liability | 5,384 | 1,834 | |||
Interest expense | 2,143,840 | ||||
Financing costs | 264,435 | ||||
Foreign exchange loss (gain) | 233,059 | ||||
Foreign exchange loss (gain) on re-translation of lease | 718 | ||||
Loss on debt modification | 99,569 | ||||
Loss on debt settlement | 491,643 | ||||
Loss (gain) on fair value of debentures | (2,256,437) | (3,041,056) | |||
Accretion of non-current liabilities | 2,597,487 | 631,701 | |||
Gain on debt settlement | (7,117,420) | ||||
Gain on EPA debt settlement | (8,614,103) | ||||
Changes in operating assets and liabilities: | |||||
Accounts receivable and prepaid expenses | (113,184) | (1,145,727) | |||
Accounts payable | (1,393,749) | 947,699 | |||
Accrued liabilities | (101,498) | 526,322 | |||
Accrued EPA/IDEQ water treatment | (903,565) | ||||
Prepaid finance costs | 393,640 | ||||
Deposit on plant demobilization | (1,000,000) | ||||
EPA cost recovery payable | (2,000,000) | ||||
Interest payable - EPA | (113,579) | ||||
Interest payable | 1,593,181 | (639,402) | |||
Net cash used in operating activities | (9,564,054) | (17,055,674) | |||
Investing activities | |||||
Additions to Bunker Hill Mine and mining interests | (1,094,037) | (5,880,471) | |||
Land purchase | (202,000) | ||||
Process plant | (5,818,688) | (2,815,398) | |||
Purchase of equipment | (219,751) | (316,600) | |||
Purchase of spare parts inventory | (341,004) | ||||
Net cash used in investing activities | (7,132,476) | (9,555,473) | |||
Financing activities | |||||
Proceeds from stream obligation | 46,000,000 | ||||
Transaction costs stream obligation | (740,956) | ||||
Proceeds from convertible debentures | 29,000,000 | ||||
Proceeds from issuance of shares, net of issue costs | 7,769,745 | ||||
Proceeds from issuance of special warrants | 3,661,822 | ||||
Proceeds from warrants exercise | 837,459 | ||||
Proceeds from promissory note | 390,000 | ||||
Repayment of bridge loan | (5,000,000) | ||||
Repayment of promissory notes | (654,315) | (1,000,000) | |||
Lease payments | (145,090) | (64,828) | |||
Net cash provided by financing activities | 44,348,920 | 35,704,917 | |||
Net change in cash | 27,652,390 | 9,093,770 | |||
Cash and restricted cash, beginning of period | 7,184,105 | 486,063 | $ 486,063 | ||
Cash and restricted cash, end of period | 34,836,495 | 9,579,833 | 34,836,495 | 9,579,833 | 7,184,105 |
Supplemental disclosures | |||||
Cash interest paid | 322,708 | ||||
Non-cash activities | |||||
Accounts payable, accrued liabilities, and promissory notes settled with special warrants issuance | 874,198 | 228,421 | |||
Mill purchase for shares and warrants | 3,243,296 | ||||
Units issued to settle DSU/RSU/Bonuses | 872,399 | ||||
Interest payable settled with common shares | 2,039,282 | 643,906 | |||
Reconciliation from Cash Flow Statement to Balance Sheet: | |||||
Cash and restricted cash end of period | 34,836,495 | 9,579,833 | 34,836,495 | 9,579,833 | |
Less restricted cash | 6,476,000 | 9,476,000 | 6,476,000 | 9,476,000 | $ 6,476,000 |
Cash end of period | $ 28,360,495 | $ 103,833 | $ 28,360,495 | $ 103,833 |
Condensed Interim Consolidate_5
Condensed Interim Consolidated Statements of Changes in Shareholders' Deficiency (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Balance | $ (34,242,368) | $ (26,176,943) | $ (34,242,368) | ||
Stock-based compensation | 1,348,851 | 188,477 | |||
Compensation options | 111,971 | 264,435 | |||
Shares issued for RSUs vested | |||||
Non brokered shares issued for $0.30 CAD | 352,855 | ||||
Stock subscription received for units | 1,775,790 | ||||
Contractor shares issued for $0.30 CAD | 290,000 | ||||
Shares issued for Mill purchase | 1,970,264 | ||||
Issue costs | (900,531) | ||||
Warrant valuation | (6,246,848) | ||||
Shares issued for warrant exercise | 907,090 | ||||
Shares issued for interest payable | 2,308,191 | 643,906 | |||
Special warrant shares issued for $0.30 CAD | 7,425,377 | 7,307,967 | |||
OCI | $ 68,738 | $ 625,050 | 502,335 | 996,636 | |
Net income (loss) for the period | 7,447,860 | 3,690,353 | (7,618,775) | 12,864,248 | |
Balance | $ (21,191,903) | (14,735,169) | (21,191,903) | (14,735,169) | |
Common Stock [Member] | |||||
Balance | $ 164 | $ 228 | $ 164 | ||
Balance, shares | 164,435,829 | 229,501,661 | 164,435,829 | ||
Stock-based compensation | |||||
Compensation options | |||||
Shares issued for RSUs vested | $ 6 | $ 2 | |||
Shares issued for RSUs vested, shares | 5,767,218 | 966,750 | |||
Non brokered shares issued for $0.30 CAD | $ 1 | ||||
Stock subscription received for units | |||||
Contractor shares issued for $0.30 CAD | 1 | ||||
Shares issued for Mill purchase | 10 | ||||
Issue costs | |||||
Warrant valuation | |||||
Shares issued for warrant exercise | $ 10 | ||||
Shares issued for warrant exercise, shares | 10,416,667 | ||||
Shares issued for interest payable | $ 20 | $ 3 | |||
Shares issued for interest payable, shares | 0 | 20,125,209 | 3,291,339 | ||
Special warrant shares issued for $0.30 CAD | $ 52 | $ 38 | |||
pecial warrant shares issued for $0.30 CAD, shares | 51,633,727 | 37,849,325 | |||
OCI | |||||
Net income (loss) for the period | |||||
Balance | $ 316 | $ 219 | $ 316 | $ 219 | |
Balance, shares | 317,444,482 | 219,649,574 | 317,444,482 | 219,649,574 | |
Non brokered shares issued for $0.30 CAD, shares | 1,471,664 | ||||
Contractor shares issued for $0.30 CAD, shares | 1,218,000 | ||||
Shares issued for Mill purchase, shares | 10,416,667 | ||||
Additional Paid-in Capital [Member] | |||||
Balance | $ 38,248,618 | $ 45,161,513 | $ 38,248,618 | ||
Stock-based compensation | 1,348,851 | 188,477 | |||
Compensation options | 111,971 | 264,435 | |||
Shares issued for RSUs vested | (6) | (2) | |||
Non brokered shares issued for $0.30 CAD | 352,854 | ||||
Stock subscription received for units | |||||
Contractor shares issued for $0.30 CAD | 289,999 | ||||
Shares issued for Mill purchase | 1,970,254 | ||||
Issue costs | (900,531) | ||||
Warrant valuation | (6,246,848) | ||||
Shares issued for warrant exercise | 907,080 | ||||
Shares issued for interest payable | 2,308,171 | 643,903 | |||
Special warrant shares issued for $0.30 CAD | 7,425,325 | 9,083,719 | |||
OCI | |||||
Net income (loss) for the period | |||||
Balance | $ 57,262,905 | $ 43,894,878 | 57,262,905 | 43,894,878 | |
Stock Subscriptions Payable [Member] | |||||
Balance | |||||
Stock-based compensation | |||||
Compensation options | |||||
Shares issued for RSUs vested | |||||
Non brokered shares issued for $0.30 CAD | |||||
Stock subscription received for units | 1,775,790 | ||||
Contractor shares issued for $0.30 CAD | |||||
Shares issued for Mill purchase | |||||
Issue costs | |||||
Warrant valuation | |||||
Shares issued for warrant exercise | |||||
Shares issued for interest payable | |||||
Special warrant shares issued for $0.30 CAD | (1,775,790) | ||||
OCI | |||||
Net income (loss) for the period | |||||
Balance | |||||
AOCI Attributable to Parent [Member] | |||||
Balance | 253,875 | ||||
Stock-based compensation | |||||
Compensation options | |||||
Shares issued for RSUs vested | |||||
Non brokered shares issued for $0.30 CAD | |||||
Stock subscription received for units | |||||
Contractor shares issued for $0.30 CAD | |||||
Shares issued for Mill purchase | |||||
Issue costs | |||||
Warrant valuation | |||||
Shares issued for warrant exercise | |||||
Shares issued for interest payable | |||||
Special warrant shares issued for $0.30 CAD | |||||
OCI | 502,335 | 996,636 | |||
Net income (loss) for the period | |||||
Balance | 756,210 | 996,636 | 756,210 | 996,636 | |
Retained Earnings [Member] | |||||
Balance | $ (72,491,150) | (71,592,559) | (72,491,150) | ||
Stock-based compensation | |||||
Compensation options | |||||
Shares issued for RSUs vested | |||||
Non brokered shares issued for $0.30 CAD | |||||
Contractor shares issued for $0.30 CAD | |||||
Shares issued for Mill purchase | |||||
Issue costs | |||||
Warrant valuation | |||||
Shares issued for warrant exercise | |||||
Shares issued for interest payable | |||||
Special warrant shares issued for $0.30 CAD | |||||
OCI | |||||
Net income (loss) for the period | (7,618,775) | 12,864,248 | |||
Balance | $ (79,211,334) | $ (59,626,902) | $ (79,211,334) | $ (59,626,902) |
Condensed Interim Consolidate_6
Condensed Interim Consolidated Statements of Changes in Shareholders' Deficiency (Unaudited) (Parenthetical) - $ / shares | Sep. 30, 2023 | Sep. 30, 2022 |
Special Warrant [Member] | ||
Class of Stock [Line Items] | ||
Shares issued price per share | $ 0.15 | $ 0.30 |
Non Brokered Shares [Member] | ||
Class of Stock [Line Items] | ||
Shares issued price per share | 0.30 | |
Contractor Shares [Member] | ||
Class of Stock [Line Items] | ||
Shares issued price per share | $ 0.30 |
Nature and Continuance of Opera
Nature and Continuance of Operations | 9 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Nature and Continuance of Operations | 1. Nature and Continuance of Operations Bunker Hill Mining Corp. (the “Company”) was incorporated under the laws of the state of Nevada The Company was incorporated for the purpose of engaging in mineral exploration, and exploitation activities. It continues to work at developing its project with a view towards putting it into production. |
Significant Accounting Policies
Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | 2. Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission for interim financial information. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, shareholders’ deficiency, or cash flows. It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments) have been made which are necessary for a fair financial statement presentation. The unaudited condensed interim consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K, which contains the annual audited consolidated financial statements and notes thereto, together with the Management’s Discussion and Analysis, for the year ended December 31, 2022. The interim results for the period ended September 30, 2023, are not necessarily indicative of the results for the full fiscal year. The unaudited condensed interim consolidated financial statements are presented in United States dollars, which is the Company’s functional currency. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes for items such as mineral reserves, useful lives and depreciation methods, potential impairment of long-lived assets, sale of mineral properties for the accounting of the conversion of the royalty convertible debenture (the “RCD”), deferred income taxes, settlement pricing of commodity sales, fair value of stock based compensation, accrued liabilities, estimation of asset retirement obligations and reclamation liabilities, convertible debentures, stream obligation, and warrants. Estimates are based on historical experience and various other assumptions that the Company believes to be reasonable. Actual results could differ from those estimates. |
Accounts receivable and prepaid
Accounts receivable and prepaid expenses | 9 Months Ended |
Sep. 30, 2023 | |
Credit Loss [Abstract] | |
Accounts receivable and prepaid expenses | 3. Accounts receivable and prepaid expenses Accounts receivable and prepaid expenses consists of the following: Schedule of Accounts receivable and prepaid expenses September 30, December 31, 2023 2022 Prepaid expenses and deposits $ 595,318 $ 386,218 Environment protection agency overpayment (note 6) 90,000 170,729 Total $ 685,318 $ 556,947 |
Equipment, Right-of-Use asset,
Equipment, Right-of-Use asset, and Process Plant | 9 Months Ended |
Sep. 30, 2023 | |
Property, Plant and Equipment [Abstract] | |
Equipment, Right-of-Use asset, and Process Plant | 4. Equipment, Right-of-Use asset, and Process Plant Equipment consists of the following: Schedule of Equipment September 30, December 31, 2023 2022 Equipment $ 1,140,324 $ 920,571 Equipment, gross 1,140,324 920,571 Less accumulated depreciation (476,136 ) (369,367 ) Equipment, net $ 664,188 $ 551,204 The total depreciation expense relating to equipment during the three and nine months ended September 30, 2023, was $ 30,344 106,769 42,814 119,905 Process Plant On May 13, 2022, the Company completed the purchase of a package of equipment and parts inventory from Teck Resources Limited’s (“Teck”) Pend Oreille operation. The package comprises substantially all the mineral processing equipment including complete crushing, grinding and flotation circuits suitable for a planned ~1,500 ton-per-day operation at the Bunker Hill site, and total inventory of components and parts for the mill, assay lab, conveyer, field instruments, and electrical spares. The purchase of the mill has been valued at: - Cash consideration given, comprised of $ 500,000 231,000 731,000 - Value of common shares issued on May 13, 2022 at the market price of that day, a value of $ 1,970,264 - Fair value of the warrants issued together with the inputs, as determined by a binomial model, resulted in a fair value of $ 1,273,032 - As a result, the total value of the mill at the time of purchase was determined to be $ 3,974,296 341,004 The process plant was purchased in an assembled state, and included major processing systems, significant components, and a large inventory of spare parts. The Company has disassembled and transported it to the Bunker Hill site, and will be reassembling it as an integral part of the Company’s future operations. The Company determined that the transaction should be accounted for as an asset acquisition, with the process plant representing a single asset, with the exception of the inventory of spare parts, which has been separated out and appears on the balance sheets as a non-current asset in accordance with the purchase price allocation. As the plant is demobilized, transported and reassembled, installation and other costs associated with these activities will be captured and capitalized as components of the asset. Process plant consists of the following: Schedule of Plant Asset Consists September 30, December 31, 2023 2022 Plant purchase price less inventory $ 3,633,292 $ 3,633,292 Ball mill purchase 745,626 - Demobilization 2,204,539 2,201,414 Site preparation costs 6,967,036 2,296,266 Process Plant $ 13,550,493 $ 8,130,972 On June 30, 2023, the Company made the final payment of $ 545,626 745,626 100,000 Right-of-use asset consists of the following: Schedule of Right-of-use Asset September 30, December 31, 2023 2022 Loader leases 163,205 - Loader leases accumulated depreciation (19,656 ) - Right-of-use asset, net $ 143,549 $ - The total depreciation expense during the three and nine months ended September 30, 2023, was $ 6,887 19,656 nil 52,353 |
Bunker Hill Mine and Mining Int
Bunker Hill Mine and Mining Interests | 9 Months Ended |
Sep. 30, 2023 | |
Extractive Industries [Abstract] | |
Bunker Hill Mine and Mining Interests | 5. Bunker Hill Mine and Mining Interests Bunker Hill Mine Purchase The Company purchased the Bunker Hill Mine (the “Mine”) in January 2022, as described below. Prior to purchasing the Mine, the Company had entered into a series of agreements with Placer Mining Corporation (“Placer Mining”), the prior owner, for the lease and option to purchase the Mine. The first of these agreements was announced on August 28, 2017, with subsequent amendments and/or extensions announced on November 1, 2019, July 7, 2020, and November 20, 2020. Under the terms of the November 20, 2020, amended agreement (the “Amended Agreement”), a purchase price of $ 7,700,000 5,700,000 300,000 2,000,000 2,000,000 3,400,000 2,000,000 The Amended Agreement also required payments pursuant to an agreement with the Environmental Protection Agency (“EPA”) whereby for so long as the Company leases, owns and/or occupies the Mine, the Company would make payments to the EPA on behalf of Placer Mining in satisfaction of the EPA’s claim for historical water treatment cost recovery as per the Settlement Agreement reached with the EPA in 2018. Immediately prior to the purchase of the Mine, the Company’s liability to EPA in this regard totaled $ 11,000,000 The Company completed the purchase of the Mine on January 7, 2022. The terms of the purchase price were modified to $ 5,400,000 3,400,000 2,000,000 8,000,000 The $ 5,400,000 7,700,000 2,000,000 300,000 The purchase of the mine has been valued on January 7, 2022: - Contract purchase price of $ 7,700,000 300,000 - Net present value of water treatment cost recovery liability assumed of $ 6,402,425 - Capitalized legal and closing costs of $ 444,785 - As a result, the total value of the mine at the time of purchase was determined to be $ 14,247,210 The Company completed the purchase of the Mine on January 7, 2022. The terms of the purchase price were modified to $ 5,400,000 3,400,000 2,000,000 8,000,000 Management has determined the purchase to be an acquisition of a single asset. Capitalized Development Commencing on October 1, 2022, the Company capitalizes mine development. Through September 30, 2023, a total of $ 2,218,439 Sale of Mineral Properties On June 23, 2023, as consideration for the extinguishment of the RCD, as described in note 7, the Company granted a royalty for 1.85 This transaction is treated as a sale of mineral interest to Sprott. The portion of the mineral interest sold was determined based on an analysis of discounted life-of-mine royalty payments relative to discounted future cash flows generated from the mine net of capital and operating costs, applied to the carrying value of the Bunker Hill Mine as of June 23, 2023 before consideration of the sale of mineral properties. This analysis utilized a discount rate of 13% and long-term metal prices of $1.09/lb, $0.98/lb and $25.51/oz for zinc, lead and silver respectively, consistent with assumptions utilized in the valuation of the RCD at extinguishment. The Company has recognized a gain of $ 6,980,932 The carrying cost of the Mine is comprised of the following: Schedule of Mining Interests September 30, December 31, 2023 2022 Bunker Hill Mine purchase $ 14,247,210 $ 14,247,210 Capitalized development 2,218,440 1,447,435 Sale of mineral properties (note 7) (1,973,840 ) - Bunker Hill mine $ 14,491,810 $ 15,694,645 Land purchase and lease On March 3, 2022, the Company purchased a 225-acre surface land parcel for $ 202,000 During the nine months ended September 30, 2023, the Company entered into a lease agreement with C & E Tree Farm LLC for the lease of a land parcel overlaying a portion of the Company’s existing mineral claims package. The Company is committed to making monthly payments of $ 10,000 3,129,500 |
Environmental Protection Agency
Environmental Protection Agency and Water Treatment Liabilities (“EPA”) | 9 Months Ended |
Sep. 30, 2023 | |
Environmental Remediation Obligations [Abstract] | |
Environmental Protection Agency and Water Treatment Liabilities (“EPA”) | 6. Environmental Protection Agency and Water Treatment Liabilities (“EPA”) Effective December 19, 2021, the Company entered into an amended Settlement Agreement between the Company, Idaho Department of Environmental Quality, US Department of Justice, and the EPA (the “Amended Settlement”). Upon the effectivity of the Amended Settlement, the Company would become fully compliant with its payment obligations to these parties. The Amended Settlement modified the payment schedule and payment terms for recovery of the historical environmental costs. Pursuant to the terms of the Amended Settlement, upon purchase of the Bunker Hill Mine and the satisfaction of financial assurance commitments (as described below), the $ 19,000,000 of cost recovery liabilities will be paid by the Company to the EPA on the following dates: Schedule of Amended Settlement Environmental Protection Agency Agreement Date Amount Within 30 days of Settlement Agreement $ 2,000,000 November 1, 2024 $ 3,000,000 November 1, 2025 $ 3,000,000 November 1, 2026 $ 3,000,000 November 1, 2027 $ 3,000,000 November 1, 2028 $ 3,000,000 November 1, 2029 $ 2,000,000 In addition to the changes in payment terms and schedule, the Amended Settlement included a commitment by the Company to secure $ 17,000,000 The Company completed the purchase of the Mine (see note 5) and made the initial $ 2,000,000 17,000,000 8,000,000 9,000,000 6,402,425 3,000,000 5,000,000 3,402,425 During the year ended 2022, the financial assurance was put into place, enabling the restructuring of the payment under the Amendment Settlement with the entire $ 17,000,000 9,999,000 5,000,000 2,001,000 4,475,000 20,000 6,476,000 6,476,000 The Company recorded accretion expense on the liability of $ 420,518 1,191,487 9,132,953 154,743 Water Treatment Charges – Idaho Department of Environmental Quality Separate to the cost recovery liability outlined above, the Company is responsible for the payment of ongoing water treatment charges. Water treatment charges incurred through December 31, 2021, were payable to the EPA, and charges thereafter are payable to the Idaho Department of Environmental Quality (“IDEQ”) following a handover of responsibilities for the Central Treatment Plant from the EPA to the IDEQ as of that date. The Company currently makes monthly payments of $ 100,000 100,000 90,000 170,729 |
Promissory Notes Payable and Co
Promissory Notes Payable and Convertible Debentures | 9 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
Promissory Notes Payable and Convertible Debentures | 7. Promissory Notes Payable and Convertible Debentures Promissory Notes On September 22, 2021, the Company issued a non-convertible promissory note of $ 2,500,000 15 202,000 December 31, 2023 1,000,000 504,315 10 99,569 On February 21, 2023, the Company issued a non-convertible promissory note to a related party of $ 120,000 120,000 18,000 In June 2023, the Company issued a non-convertible promissory note in the amount of $ 150,000 15,000 At September 30, 2023, the Company owes $ 1,095,253 41,410 151,821 56,712 224,589 44,560 384,041 15 Project Finance Package with Sprott Private Resource Streaming & Royalty Corp. (“SRSR”) On December 20, 2021, the Company executed a non-binding term sheet outlining a $ 50,000,000 The non-binding term sheet with SRSR outlined a $ 50,000,000 8,000,000 5,000,000 37,000,000 6,000,000 51,000,000 On June 17, 2022, the Company consummated a new $ 15,000,000 66,000,000 On June 23, 2023, the Company closed the upsized and improved $ 67,000,000 46,000,000 21,000,000 46,000,000 37,000,000 9,000,000 21,000,000 96,000,000 6 15 The Company incurred $ 254,220 21,000,000 $8,000,000 Royalty Convertible Debenture The Company closed the $ 8,000,000 9.0 1.85 Concurrent with the funding of the CD2 in June 2022, the Company and SRSR agreed to a number of amendments to the terms of the RCD, including an amendment of the maturity date from July 7, 2023 to March 31, 2025. 8,000,000 On June 23, 2023, the funding date of the Stream, the RCD was repaid by the Company granting a royalty for 1.85% of life-of-mine gross revenue (the “Royalty”) from mining claims historically worked as described above. A 1.35% rate will apply to claims outside of these areas. The Company recorded a gain on sale of mineral properties of $ 6,980,932 347,499 8 $6,000,000 Convertible Debenture (CD1) The Company closed the $ 6,000,000 5,000,000 7.5 37,000,000 0.30 Concurrent with the funding of the CD2 in June 2022, the Company and SRSR agreed to a number of amendments to the terms of the CD1, including that the maturity date would be amended from July 7, 2023 to March 31, 2025 Concurrent with the funding of the Stream in June 2023, the Company and SRSR agreed to amend the maturity date of CD1 from March 31, 2025, to March 31, 2026, and that CD1 would remain outstanding until the new maturity date unless the company elects to exercise its option of early repayment. The Company determined that the amendments to the terms of the CD1 should not be treated as an extinguishment of the CD1 and have therefore been accounted for as a modification. $15,000,000 Series 2 Convertible Debenture (CD2) The Company closed the $ 15,000,000 10.5 0.29 2,000,000 9,000,000 Concurrent with the funding of the Stream in June 2023, the Company and SRSR agreed to amend the maturity date of the CD2 from 3 quarterly payments of $ 2,000,000 9,000,000 The Company determined that in accordance with ASC 815 derivatives and hedging, each debenture will be valued and carried as a single instrument, with the periodic changes to fair value accounted through earnings, profit and loss. Consistent with the approach above, the following table summarizes the key valuation inputs as at applicable valuation dates: Schedule of Key Valuation Inputs Reference (2)(4) (5) Valuation Maturity Contractual Stock price (US$) Expected equity volatility Credit spread Risk-free rate Risk- CD1 note(3) (2)(4)(5 )(3) 12-31-22 03-31-25 7.50 % 0.125 120 % 7.08 % 4.32 % 17.85 % RCD note (2)(4)(5) 12-31-22 03-31-25 9.00 % 0.125 120 % 7.08 % 4.32 % 17.85 % CD2 note(3) (2)(4 )(5)(3) 12-31-22 03-31-25 10.50 % 0.125 120 % 7.08 % 4.32 % 19.76 % CD1 note(3) (2)(4)(5)(3) 03-31-23 03-31-25 7.50 % 0.082 115 % 11.22 % 4.06 % 21.33 % RCD note(5) (2)(4)(5) 03-31-23 03-31-25 9.00 % 0.082 115 % 11.22 % 4.06 % 21.33 % CD2 note(3) (2)(4)(5)(3) 03-31-23 03-31-25 10.50 % 0.082 115 % 11.22 % 4.06 % 23.20 % RCD note (2)(4)(5) 06-23-23 03-31-25 9.00 % 0.169 120 % 8.28 % 4.83 % 19.37 % CD1 note(3) (2)(4)(5)(3) 06-30-23 03-31-26 7.50 % 0.186 120 % 7.93 % 4.58 % 18.83 % CD2 note(3) (2)(4)(5)(3) 06-30-23 03-31-26 10.50 % 0.186 120 % 7.93 % 4.58 % 20.73 % CD1 note(3) (2)(4)(5)(3) 09-30-23 03-31-26 7.50 % 0.104 115 % 8.65 % 4.91 % 19.78 % CD2 note(3) (2)(4)(5)(3) 09-30-23 03-31-26 10.50 % 0.104 115 % 8.65 % 4.91 % 21.67 % Convertible Debenture (2)(4)(5)(3) 09-30-23 03-31-26 10.50 % 0.104 115 % 8.65 % 4.91 % 21.67 % (1) The CD1 carried a Discount for Lack of Marketability (“DLOM”) of 5.0 10.0 (2) CD1 and RCD carry an instrument-specific spread of 7.23 9.32 (3) The conversion price of the CD1 is $ 0.219 0.226 0.219 0.212 (4) A project risk rate of 13.0 (5) The valuation of the RCD is driven by the aggregation of (i) the present value of future potential cash flow to the royalty holder, in the event that the RCD is converted to a royalty, utilizing an estimate of future metal sales and Monte Carlo simulations of future metal prices, and (ii) the computation of the present value assuming no conversion to the 1.85 1.85 77 The resulting fair values of the CD1, RCD, and CD2 at September 30, 2023, and as of December 31, 2022, were as follows: Schedule of Fair Value Derivative Liability Instrument Description September 30, 2023 December 31, 2022 CD1 $ 5,190,551 $ 5,537,360 RCD - 10,285,777 CD2 12,746,242 14,063,525 Total $ 17,936,793 $ 29,886,662 The total gain on fair value of debentures recognized during the three and nine months ended September 30, 2023 was $ 2,450,968 and $ 2,256,437 , respectively, and $ 1,301,069 and $ 3,041,056 for the three and nine months ended September 30, 2022, respectively. The portion of changes in fair value attributable to changes in the Company’s credit risk is accounted for within other comprehensive (loss) income during the three and nine months ended September 30, 2023 was $ 68,738 and $ 502,335 , respectively. Compared to the three and nine months ended September 30, 2022 was $ 625,050 and $ 996,636 , respectively. Interest expense for the three and nine months ended September 30, 2023 was $ 510,411 and $ 1,857,822 , respectively. Compared to the three and nine months ended September 30, 2022 was $ 691,111 and $ 1,279,849 , respectively. At September 30, 2023 interest of $ 510,411 ($ 691,890 at December 31, 2022) is included in interest payable on the consolidated balance sheets. For the three and nine months ended September 30, 2023 the Company recognized $ nil and $ 268,889 , respectively, loss on debt settlement in the unaudited condensed interim consolidated statements of (loss) income and comprehensive (loss) income as a result of settling interest by issuance of shares ( 0 20,125,209 nil and $ nil , respectively. The Company performs quarterly testing of the covenants in the CD1 and CD2 and was in compliance with all such covenants as of September 30, 2023. $5,000,000 Bridge Loan On December 6, 2022, the Company closed a $ 5,000,000 The Bridge Loan bears interest at 10.5% per annum and matures at the earlier of (i) the advance of the Stream, or (ii) June 30, 2024. In addition, the minimum quantity of metal delivered under the Stream, if advanced, would increase by 5 On June 23, 2023 the Company repaid the outstanding principal and interest on the Bridge Loan recognizing a loss on extinguishment of debt of $ 222,754 nil 53,985 168,166 346,550 nil nil $46,000,000 Stream On June 23, 2023, all conditions were met for the closing of the Stream, and $ 46,000,000 824,156 45,175,844 The Company determined that in accordance with ASC 815 derivatives and hedging, the Stream does not meet the criteria for treatment as a derivate instrument as the quantities of metal to be sold thereunder are not subject to a minimum quantity, and therefore a notional amount is not determinable. The Company has therefore determined that in accordance with ASC 470, the stream obligation should be treated as a liability based on the indexed debt rules thereunder. The initial recognition has been made at fair value based on cash received, net of transaction costs, and the discount rate calibrated so that the future cash flows associated with the Stream, using forward commodity prices, equal the cash received. The measurement of the stream obligation is accounted for at amortized cost with accretion at the discount rate. Subsequent changes to the expected cash flows associated with the Stream will result in the adjustment of the carrying value of the stream obligation using the same discount rate, with changes to the carrying value recognized in the unaudited condensed interim consolidated statements of income. The Company determined the effective interest rate of the Stream obligation to be 11.4 1,321,000 1,406,000 nil 46,665,044 $21,000,000 Debt Facility On June 23, 2023 the Company closed a $ 21,000,000 2 10 The maturity date of any drawings under the Debt Facility will be June 23, 2027 5 20 |
Capital Stock, Warrants and Sto
Capital Stock, Warrants and Stock Options | 9 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
Capital Stock, Warrants and Stock Options | 8. Capital Stock, Warrants and Stock Options Authorized The total authorized capital is as follows: ● 1,500,000,000 0.000001 ● 10,000,000 0.000001 Issued and outstanding In April 2022, the Company closed a private placement of 37,849,325 1,471,664 9,384,622 11,796,297 4,809,160 The Special Warrants were issued at a price of C$ 0.30 0.37 On May 31, 2022, the Company announced that it had received a receipt from the Ontario Securities Commission for its final short-form Canadian prospectus qualifying the distribution of the common stock of the Company and common stock purchase warrants of the Company issuable upon exercise of the special warrants of the Company that were issued on April 1, 2022. The Company also announced that it received notice from the United States Securities and Exchange Commission that its Form S-1 has been declared effective as of May 27, 2022. As a result of obtaining the receipt for the Canadian prospectus and the declaration of effectiveness for the Form S-1, each unexercised Special Warrant was automatically exercised into one Common Share and one Warrant without further action on the part of the holders. The non-brokered 1,471,664 0.30 0.37 In connection with the special warrants offering, the agents earned a cash commission in the amount of C$ 563,968 1,879,892 0.30 0.37 In April 2022, the Company issued 1,315,856 In May 2022, the Company issued 10,416,667 0.245 0.37 In June 2022, the Company issued 1,218,000 0.37 In July 2022, the Company issued 1,975,482 In March 2023, the Company amended the exercise price and expiry date of 10,416,667 0.37 0.37 0.11 March 31, 2023 214,714 10,416,667 0.11 837,460 1,145,834) nil 400,152) 120 0.11 3.42 4.06 0 In March 2023, the Company closed a brokered private placement of special warrants (the “March 2023 Offering”), issuing 51,633,727 0.12 4,536,020 6,196,047 3,661,822 874,198 Each March 2023 Unit consists of one share of Common Share of the Company (each, a “Unit Share”) and one common stock purchase warrant of the Company (each, a “Warrant”). Each whole Warrant entitles the holder thereof to acquire one Common Share of the Company (a “Warrant Share”, and together with the Unit Shares, the “Underlying Shares”) at an exercise price of C$0.15 per Warrant Share until March 27, 2026, subject to adjustment in certain events. In the event that the Registration Statement has not been declared effective by the SEC on or before 5:00 p.m. (EST) on July 27, 2023, each unexercised Special Warrant will be deemed to be exercised on the Automatic Exercise Date into one penalty unit of the Company (each, a “Penalty Unit”), with each Penalty Unit being comprised of 1.2 Unit Shares and 1.2 Warrants. Notice of such effectiveness was received on July 11, 2023, eliminating the potential for issuance of the Penalty Units. In connection with the March 2023 Offering, the Company incurred share issuance costs of $ 846,661 2,070,258 0.12 The Special Warrants issued on March 27, 2023 were converted to 51,633,727 The fair value of the Special Warrant is determined through the valuation of the Unit Share based on the observed price of the Company’s Common Shares, a Level 1 input, together with a valuation of the warrant component of the March 2023 Unit using the Binomial model calibrated with inputs as shown in the table below. Consistent with the approach above, the following table summarizes the key valuation inputs as at applicable valuation dates: Schedule of Estimated Fair Value of Special Warrant Liabilities March 2023 special warrants Conversion Grant Date Expected life 977 1096 Volatility 24 % 24 % Risk free interest rate 4.64 % 3.40 % Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.11 Fair value of March 2023 Unit $ 9,809,314 $ 4,536,020 Change in derivative liability $ 5,273,294 Common Stock $ 7,425,377 Warrant $ 2,383,937 For prior financings, excluding the March 2023 Special Warrants, the Company has accounted for warrants in accordance with ASC 815 derivatives and hedging. The warrants are considered derivative instruments as they were issued in a currency other than the Company’s functional currency of the United States Dollars. The estimated fair value of warrants accounted for as liabilities was determined on the date of issue and marked to market at each financial reporting period. The change in fair value of the warrant is recorded in the unaudited condensed interim consolidated statements of income (loss) and comprehensive (loss) income as a gain or loss and is estimated using the Binomial model. The fair value of the warrant liabilities related to the various tranches of outstanding warrants during the period were estimated using the Binomial model to determine the fair value using the following assumptions as at September 30, 2023 and December 31, 2022: Schedule of Estimated Using the Binomial Model to Determine the Fair Value of Warrant Liabilities March 2023 warrants September 30, 2023 Grant Date Expected life 909 909 Volatility 24 % 24 Risk free interest rate 4.64 % 4.33 Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.19 Fair value $ 1,149,538 $ 2,383,937 Change in derivative liability $ (1,234,399 ) April 2022 special warrants issuance September 30, 2023 December 31, 2022 Expected life 549 822 Volatility 120 % 120 % Risk free interest rate 4.87 % 4.06 % Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.17 Fair value $ 1,408,152 $ 2,406,104 Change in derivative liability $ (997,952 ) April 2022 non-brokered issuance September 30, 2023 December 31, 2022 Expected life 549 822 Volatility 120 % 120 % Risk free interest rate 4.87 % 4.06 % Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.17 Fair value $ 54,751 $ 93,553 Change in derivative liability $ (38,802 ) June 2022 issuance September 30, 2023 December 31, 2022 Expected life 549 822 Volatility 120 % 120 % Risk free interest rate 4.87 % 3.72 % Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.17 Fair value $ 45,314 $ 77,429 Change in derivative liability $ (32,115 ) February 2021 issuance September 30, 2023 December 31, 2022 Expected life 863 1,136 Volatility 120 % 120 % Risk free interest rate 4.64 % 3.72 % Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.17 Fair value $ 872,523 $ 1,335,990 Change in derivative liability $ (463,467 ) August 2020 issuance September 30, 2023 December 31, 2022 Expected life Expired 243 Volatility N/A 120 % Risk free interest rate N/A 4.06 % Dividend yield N/A 0 % Share price (C$) $ N/A $ 0.17 Fair value $ - $ 903,697 Change in derivative liability $ (903,697 ) June 2019 issuance September 30, 2023 December 31, 2022 Expected life 823 1,096 Volatility 115 % 120 % Risk free interest rate 4.87 % 3.82 % Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.17 Fair value $ 444,149 $ 725,737 Change in derivative liability $ (281,588 ) August 2019 issuance September 30, 2023 December 31, 2022 Expected life 823 1,096 Volatility 115 % 120 % Risk free interest rate 4.87 % 3.82 % Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.17 Fair value $ 682,604 $ 1,115,369 Change in derivative liability $ (432,765 ) Outstanding warrants at September 30, 2023 and September 30, 2022 were as follows: Schedule of Warrant Activity Weighted Weighted average average Number of exercise price grant date warrants (C$) value ($) Balance, December 31, 2021 111,412,712 $ 0.54 $ 0.18 Issued 50,955,636 0.37 0.15 Expired (239,284 ) 0.70 0.21 Balance, September 30, 2022 162,129,064 0.49 0.17 Balance, December 31, 2022 162,129,064 $ 0.49 $ 0.17 Issued 51,633,727 0.15 0.05 Expired (58,284,148 ) 0.50 0.27 Exercised (10,416,667 ) 0.11 0.12 Balance, September 30, 2023 145,061,976 $ 0.37 $ 0.09 At September 30, 2023, the following warrants were outstanding: Schedule of Warrants Outstanding Exercise Price Exercise Number of Number of warrants Expiry date price (C$) warrants exercisable April 1, 2025 0.37 40,538,969 40,538,969 December 31, 2025 0.59 32,895,200 32,895,200 February 9, 2026 0.60 17,112,500 17,112,500 February 16, 2026 0.60 2,881,580 2,881,580 March 27, 2026 0.15 51,633,727 51,633,727 145,061,976 145,061,976 Compensation options At September 30, 2023, the following broker options were outstanding: Schedule of Compensation Options Weighted Number of average broker exercise price options (C$) Balance, December 31, 2021 3,590,907 0.35 Issued – April 2022 Compensation Options (i) 1,879,892 0.30 Balance, December 31, 2022 5,470,799 $ 0.34 Issued – March 2023 Compensation Options (ii) 2,070,258 0.15 Expired – August 2020 Compensation Options (3,239,907 ) 0.35 Balance, September 30, 2023 4,301,150 0.24 (i) The grant date fair value of the April 2022 Compensation Options were estimated at $ 264,435 Schedule of Estimated Using Black-Scholes Valuation Model for Fair Value of Broker Options Grant Date Risk free interest rate Dividend yield Volatility Stock price Weighted average life April 2022 2.34 % 0 % 120 % C$ 0.30 2 years (ii) The grant date fair value of the March 2023 Compensation Options were estimated at $ 111,971 Grant Date Risk free interest rate Dividend yield Volatility Stock price Weighted average life March 2023 3.4 % 0 % 120 % C$ 0.11 3 years Schedule of Broker Exercise Prices Exercise Number of Grant date Fair value Expiry date price (C$) broker options ($) February 16, 2024 (i) $ 0.40 351,000 $ 68,078 April 1, 2024 (ii) $ 0.30 1,879,892 $ 264,435 March 27, 2026 (iii) $ 0.15 2,070,258 $ 111,971 4,301,150 $ 444,484 i) Exercisable into one February 2021 Unit ii) Exercisable into one April 2022 Unit iii) Exercisable into one March 2023 Unit Stock options The following table summarizes the stock option activity during the nine months ended September 30, 2023: Schedule of Stock Options Weighted average Number of exercise price stock options (C$) Balance, December 31, 2021 9,053,136 $ 0.58 Granted (i) 700,000 $ 0.15 Expired, May 1, 2022 (47,000 ) $ 10.00 Forfeited (150,000 ) $ 0.15 Expired, December 31, 2022 (235,500 ) $ 0.50 Balance, December 31, 2022 9,320,636 $ 0.51 Expired, September 30, 2023 (200,000 ) $ 0.60 Balance, September 30, 2023 9,120,636 $ 0.51 (i) On August 22, 2022, the Company granted 300,000 400,000 The following table reflects the actual stock options issued and outstanding as of September 30, 2023: Schedule of Actual Stock Options Issued and Outstanding Number of remaining Number of options Grant date Exercise contractual options vested fair value price (C$) life (years) outstanding (exercisable) ($) 0.60 1.07 1,575,000 1,575,000 435,069 0.55 1.56 5,957,659 4,468,245 1,536,764 0.335 2.39 1,037,977 1,037,977 204,213 0.15 0.15 150,000 150,000 14,465 0.15 4.15 400,000 200,000 37,387 9,120,636 7,431,222 $ 2,227,898 The vesting of stock options during the three and nine months ending September 30, 2023, resulted in stock based compensation expenses of $ 27,725 120,865 72,066 241,060 |
Restricted Share Units
Restricted Share Units | 9 Months Ended |
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Restricted Share Units | 9. Restricted Share Units Effective March 25, 2020, the Board of Directors approved a Restricted Share Unit (“RSU”) Plan to grant RSUs to its officers, directors, key employees and consultants. The following table summarizes the RSU activity during the nine months ended September 30, 2023: Schedule of Restricted Share Units Weighted average grant date fair value Number of per share shares (C$) Unvested as at December 31, 2021 576,000 $ 0.62 Granted 6,620,641 0.17 Vested (2,373,900 ) 0.18 Unvested as at December 31, 2022 4,822,741 $ 0.22 Granted 10,844,993 0.23 Vested (5,767,218 ) 0.24 Unvested as at September 30, 2023 9,900,516 $ 0.22 (i) On January 10, 2022, the Company granted 500,000 122,249 (ii) On April 29, 2022, the Company granted 76,750 16,800 (iii) On June 30, 2022, the Company granted 15,000 2,328 (iv) On September 29, 2022 the Company granted 33,000 RSUs to two consultants of the Company, vesting immediately. The vesting of these RSUs resulted in stock-based compensation of $ 2,889 for the nine months ended September 30, 2022, which is included in operation and administration expenses on the unaudited condensed interim consolidated statements of income (loss) and comprehensive (loss) income. (v) On June 1, 2023, the Company granted 4,067,637 322,905 (vi) On June 4, 2023, the Company granted 42,000 7,825 (vii) On July 4, 2023, the Company granted 6,735,356 214,897 The vesting of RSU’s during the three and nine months ending September 30, 2023, resulted in stock based compensation expense of $ 271,021 865,745 14,585 53,444 |
Deferred Share Units
Deferred Share Units | 9 Months Ended |
Sep. 30, 2023 | |
Deferred Share Units | |
Deferred Share Units | 10. Deferred Share Units Effective April 21, 2020, the Board of Directors approved a Deferred Share Unit (“DSU”) Plan to grant DSUs to its directors. The DSU Plan permits the eligible directors to defer receipt of all or a portion of their retainer or compensation until termination of their services and to receive such fees in the form of cash at that time. Upon vesting of the DSUs or termination of service as a director, the director will be able to redeem DSUs based upon the then market price of the Company’s Common Share on the date of redemption in exchange for cash. The following table summarizes the DSU activity during the nine months ended September 30, 2023 and 2022: Schedule of Deferred Share Units Weighted average grant date fair value Number of per share shares (C$) Unvested as at December 31, 2021 5,625,000 $ 1.03 Vested (i) (3,125,000 ) 1.03 Unvested as at December 31, 2022 2,710,000 0.97 Granted (ii, iii) 1,857,280 0.23 Vested (iv, v) (3,071,826 ) 0.55 Unvested as at September 30, 2023 1,495,454 $ 0.90 (i) On March 31, 2022, the Board approved the early vesting of 625,000 2,500,000 750,000 375,000 0.30 (ii) On July 4, 2023, 1,611,826 (iii) On July 6, 2023, 245,454 (iv) On April 21, 2023, 1,250,000 (v) On July 1, 2023, 210,000 The vesting of DSU’s during the three and nine months ending September 30, 2023, resulted in stock based compensation recovery (expense) of $ 141,969 145,355 188,194 1,083,610 |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | 11. Commitments and Contingencies As stipulated in the agreement with the EPA and as described in Note 6, the Company is required to make two types of payments to the EPA and IDEQ, one for historical water treatment cost-recovery to the EPA, and the other for ongoing water treatment. Water treatment costs incurred through December 2021 are payable to the EPA, and water treatment costs incurred thereafter are payable to the IDEQ. The IDEQ (as done formerly by the EPA) invoices the Company on an annual basis for the actual water treatment costs, which may exceed the recognized estimated costs significantly. When the Company receives the water treatment invoices, it records any liability for actual costs over and above any estimates made and adjusts future estimates as required based on these actual invoices received. The Company is required to pay for the actual costs regardless of the periodic required estimated accruals and payments made each year. On July 28, 2021, a lawsuit was filed in the US District Court for the District of Idaho brought by Crescent Mining, LLC (“Crescent”). The named defendants include Placer Mining, Robert Hopper Jr., and the Company. The lawsuit alleges that Placer Mining and Robert Hopper Jr. intentionally flooded the Crescent Mine during the period from 1991 and 1994, and that the Company is jointly and severally liable with the other defendants for unspecified past and future costs associated with the presence of Acid Mine Drainage in the Crescent Mine. The plaintiff has requested unspecified damages. On September 20, 2021, the Company filed a motion to dismiss Crescent’s claims against it, contending that such claims are facially deficient. On March 2, 2022, Chief US District Court Judge, David C. Nye granted in part and denied in part the Company’s motion to dismiss. The court granted the Company’s motion to dismiss Crescent’s Cost Recovery claim under CERCLA Section 107(a), Declaratory Judgment, Tortious Interference, Trespass, Nuisance and Negligence claims. These claims were dismissed without prejudice. The court denied the motion to dismiss filed by Placer Mining Corp. for Crescent’s trespass, nuisance and negligence claims. Crescent later filed an amended complaint on April 1, 2022. Placer Mining Corp. and Bunker Hill Mining Corp are named as co-defendants. The Company responded to the amended filing, refuting and denying all allegations made in the complaint except those that are assertions of fact as a matter of public record. The Company believes the lawsuit against Placer Mining Corp. is without merit and intends to defend Placer Mining Corp. vigorously pursuant to the Company’s indemnification of Placer Mining Corp in the Sale and Purchase agreement executed between the companies for the Mine on December 15, 2021. During the nine months ended September 30, 2023, the Company entered into a lease agreement with C & E Tree Farm LLC for the lease of a land parcel overlaying a portion of the Company’s existing mineral claims package. The Company is committed to making monthly payments of $ 10,000 |
Deferred tax liability
Deferred tax liability | 9 Months Ended |
Sep. 30, 2023 | |
Income Tax Disclosure [Abstract] | |
Deferred tax liability | 12. Deferred tax liability The Company incurred income tax recovery (expense) of $ 0.90 2.61 no 52.0 0.0 35.8 A valuation allowance is provided for deferred tax assets for which it is more likely than not that the related tax benefits will not be realized. The Company analyzes its deferred tax assets and, if it is determined that the Company will not realize all or a portion of its deferred tax assets, it will record or increase a valuation allowance. Conversely, if it is determined that the Company will likely ultimately be able to realize all or a portion of the related benefits for which a valuation allowance has been provided, all or a portion of the related valuation allowance will be reduced. |
Related party transactions
Related party transactions | 9 Months Ended |
Sep. 30, 2023 | |
Related Party Transactions [Abstract] | |
Related party transactions | 13. Related party transactions The Company’s key management personnel have the authority and responsibility for planning, directing and controlling the activities of the Company and consists of the Company’s executive management team and management directors. Schedule of Related Party Transactions Three Months Three Months Nine Months Nine Months September 30, September 30, September 30, September 30, 2023 2022 2023 2022 Consulting fees & wages $ 225,061 $ 248,472 $ 797,978 $ 1,832,323 At September 30, 2023 and September 30, 2022, $ nil 15,000 |
Subsequent Events
Subsequent Events | 9 Months Ended |
Sep. 30, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events | 14. Subsequent Events In October 2023, the Company issued 5,175,000 |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission for interim financial information. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, shareholders’ deficiency, or cash flows. It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments) have been made which are necessary for a fair financial statement presentation. The unaudited condensed interim consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K, which contains the annual audited consolidated financial statements and notes thereto, together with the Management’s Discussion and Analysis, for the year ended December 31, 2022. The interim results for the period ended September 30, 2023, are not necessarily indicative of the results for the full fiscal year. The unaudited condensed interim consolidated financial statements are presented in United States dollars, which is the Company’s functional currency. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes for items such as mineral reserves, useful lives and depreciation methods, potential impairment of long-lived assets, sale of mineral properties for the accounting of the conversion of the royalty convertible debenture (the “RCD”), deferred income taxes, settlement pricing of commodity sales, fair value of stock based compensation, accrued liabilities, estimation of asset retirement obligations and reclamation liabilities, convertible debentures, stream obligation, and warrants. Estimates are based on historical experience and various other assumptions that the Company believes to be reasonable. Actual results could differ from those estimates. |
Accounts receivable and prepa_2
Accounts receivable and prepaid expenses (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Credit Loss [Abstract] | |
Schedule of Accounts receivable and prepaid expenses | Accounts receivable and prepaid expenses consists of the following: Schedule of Accounts receivable and prepaid expenses September 30, December 31, 2023 2022 Prepaid expenses and deposits $ 595,318 $ 386,218 Environment protection agency overpayment (note 6) 90,000 170,729 Total $ 685,318 $ 556,947 |
Equipment, Right-of-Use asset_2
Equipment, Right-of-Use asset, and Process Plant (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Equipment | Equipment consists of the following: Schedule of Equipment September 30, December 31, 2023 2022 Equipment $ 1,140,324 $ 920,571 Equipment, gross 1,140,324 920,571 Less accumulated depreciation (476,136 ) (369,367 ) Equipment, net $ 664,188 $ 551,204 |
Schedule of Plant Asset Consists | Process plant consists of the following: Schedule of Plant Asset Consists September 30, December 31, 2023 2022 Plant purchase price less inventory $ 3,633,292 $ 3,633,292 Ball mill purchase 745,626 - Demobilization 2,204,539 2,201,414 Site preparation costs 6,967,036 2,296,266 Process Plant $ 13,550,493 $ 8,130,972 |
Schedule of Right-of-use Asset | Right-of-use asset consists of the following: Schedule of Right-of-use Asset September 30, December 31, 2023 2022 Loader leases 163,205 - Loader leases accumulated depreciation (19,656 ) - Right-of-use asset, net $ 143,549 $ - |
Bunker Hill Mine and Mining I_2
Bunker Hill Mine and Mining Interests (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Extractive Industries [Abstract] | |
Schedule of Mining Interests | The carrying cost of the Mine is comprised of the following: Schedule of Mining Interests September 30, December 31, 2023 2022 Bunker Hill Mine purchase $ 14,247,210 $ 14,247,210 Capitalized development 2,218,440 1,447,435 Sale of mineral properties (note 7) (1,973,840 ) - Bunker Hill mine $ 14,491,810 $ 15,694,645 |
Environmental Protection Agen_2
Environmental Protection Agency and Water Treatment Liabilities (“EPA”) (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Environmental Remediation Obligations [Abstract] | |
Schedule of Amended Settlement Environmental Protection Agency Agreement | Schedule of Amended Settlement Environmental Protection Agency Agreement Date Amount Within 30 days of Settlement Agreement $ 2,000,000 November 1, 2024 $ 3,000,000 November 1, 2025 $ 3,000,000 November 1, 2026 $ 3,000,000 November 1, 2027 $ 3,000,000 November 1, 2028 $ 3,000,000 November 1, 2029 $ 2,000,000 |
Promissory Notes Payable and _2
Promissory Notes Payable and Convertible Debentures (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
Schedule of Key Valuation Inputs | Consistent with the approach above, the following table summarizes the key valuation inputs as at applicable valuation dates: Schedule of Key Valuation Inputs Reference (2)(4) (5) Valuation Maturity Contractual Stock price (US$) Expected equity volatility Credit spread Risk-free rate Risk- CD1 note(3) (2)(4)(5 )(3) 12-31-22 03-31-25 7.50 % 0.125 120 % 7.08 % 4.32 % 17.85 % RCD note (2)(4)(5) 12-31-22 03-31-25 9.00 % 0.125 120 % 7.08 % 4.32 % 17.85 % CD2 note(3) (2)(4 )(5)(3) 12-31-22 03-31-25 10.50 % 0.125 120 % 7.08 % 4.32 % 19.76 % CD1 note(3) (2)(4)(5)(3) 03-31-23 03-31-25 7.50 % 0.082 115 % 11.22 % 4.06 % 21.33 % RCD note(5) (2)(4)(5) 03-31-23 03-31-25 9.00 % 0.082 115 % 11.22 % 4.06 % 21.33 % CD2 note(3) (2)(4)(5)(3) 03-31-23 03-31-25 10.50 % 0.082 115 % 11.22 % 4.06 % 23.20 % RCD note (2)(4)(5) 06-23-23 03-31-25 9.00 % 0.169 120 % 8.28 % 4.83 % 19.37 % CD1 note(3) (2)(4)(5)(3) 06-30-23 03-31-26 7.50 % 0.186 120 % 7.93 % 4.58 % 18.83 % CD2 note(3) (2)(4)(5)(3) 06-30-23 03-31-26 10.50 % 0.186 120 % 7.93 % 4.58 % 20.73 % CD1 note(3) (2)(4)(5)(3) 09-30-23 03-31-26 7.50 % 0.104 115 % 8.65 % 4.91 % 19.78 % CD2 note(3) (2)(4)(5)(3) 09-30-23 03-31-26 10.50 % 0.104 115 % 8.65 % 4.91 % 21.67 % Convertible Debenture (2)(4)(5)(3) 09-30-23 03-31-26 10.50 % 0.104 115 % 8.65 % 4.91 % 21.67 % (1) The CD1 carried a Discount for Lack of Marketability (“DLOM”) of 5.0 10.0 (2) CD1 and RCD carry an instrument-specific spread of 7.23 9.32 (3) The conversion price of the CD1 is $ 0.219 0.226 0.219 0.212 (4) A project risk rate of 13.0 (5) The valuation of the RCD is driven by the aggregation of (i) the present value of future potential cash flow to the royalty holder, in the event that the RCD is converted to a royalty, utilizing an estimate of future metal sales and Monte Carlo simulations of future metal prices, and (ii) the computation of the present value assuming no conversion to the 1.85 1.85 77 |
Schedule of Fair Value Derivative Liability | The resulting fair values of the CD1, RCD, and CD2 at September 30, 2023, and as of December 31, 2022, were as follows: Schedule of Fair Value Derivative Liability Instrument Description September 30, 2023 December 31, 2022 CD1 $ 5,190,551 $ 5,537,360 RCD - 10,285,777 CD2 12,746,242 14,063,525 Total $ 17,936,793 $ 29,886,662 |
Capital Stock, Warrants and S_2
Capital Stock, Warrants and Stock Options (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
Schedule of Estimated Fair Value of Special Warrant Liabilities | Consistent with the approach above, the following table summarizes the key valuation inputs as at applicable valuation dates: Schedule of Estimated Fair Value of Special Warrant Liabilities March 2023 special warrants Conversion Grant Date Expected life 977 1096 Volatility 24 % 24 % Risk free interest rate 4.64 % 3.40 % Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.11 Fair value of March 2023 Unit $ 9,809,314 $ 4,536,020 Change in derivative liability $ 5,273,294 Common Stock $ 7,425,377 Warrant $ 2,383,937 |
Schedule of Estimated Using the Binomial Model to Determine the Fair Value of Warrant Liabilities | The fair value of the warrant liabilities related to the various tranches of outstanding warrants during the period were estimated using the Binomial model to determine the fair value using the following assumptions as at September 30, 2023 and December 31, 2022: Schedule of Estimated Using the Binomial Model to Determine the Fair Value of Warrant Liabilities March 2023 warrants September 30, 2023 Grant Date Expected life 909 909 Volatility 24 % 24 Risk free interest rate 4.64 % 4.33 Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.19 Fair value $ 1,149,538 $ 2,383,937 Change in derivative liability $ (1,234,399 ) April 2022 special warrants issuance September 30, 2023 December 31, 2022 Expected life 549 822 Volatility 120 % 120 % Risk free interest rate 4.87 % 4.06 % Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.17 Fair value $ 1,408,152 $ 2,406,104 Change in derivative liability $ (997,952 ) April 2022 non-brokered issuance September 30, 2023 December 31, 2022 Expected life 549 822 Volatility 120 % 120 % Risk free interest rate 4.87 % 4.06 % Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.17 Fair value $ 54,751 $ 93,553 Change in derivative liability $ (38,802 ) June 2022 issuance September 30, 2023 December 31, 2022 Expected life 549 822 Volatility 120 % 120 % Risk free interest rate 4.87 % 3.72 % Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.17 Fair value $ 45,314 $ 77,429 Change in derivative liability $ (32,115 ) February 2021 issuance September 30, 2023 December 31, 2022 Expected life 863 1,136 Volatility 120 % 120 % Risk free interest rate 4.64 % 3.72 % Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.17 Fair value $ 872,523 $ 1,335,990 Change in derivative liability $ (463,467 ) August 2020 issuance September 30, 2023 December 31, 2022 Expected life Expired 243 Volatility N/A 120 % Risk free interest rate N/A 4.06 % Dividend yield N/A 0 % Share price (C$) $ N/A $ 0.17 Fair value $ - $ 903,697 Change in derivative liability $ (903,697 ) June 2019 issuance September 30, 2023 December 31, 2022 Expected life 823 1,096 Volatility 115 % 120 % Risk free interest rate 4.87 % 3.82 % Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.17 Fair value $ 444,149 $ 725,737 Change in derivative liability $ (281,588 ) August 2019 issuance September 30, 2023 December 31, 2022 Expected life 823 1,096 Volatility 115 % 120 % Risk free interest rate 4.87 % 3.82 % Dividend yield 0 % 0 % Share price (C$) $ 0.15 $ 0.17 Fair value $ 682,604 $ 1,115,369 Change in derivative liability $ (432,765 ) |
Schedule of Warrant Activity | Outstanding warrants at September 30, 2023 and September 30, 2022 were as follows: Schedule of Warrant Activity Weighted Weighted average average Number of exercise price grant date warrants (C$) value ($) Balance, December 31, 2021 111,412,712 $ 0.54 $ 0.18 Issued 50,955,636 0.37 0.15 Expired (239,284 ) 0.70 0.21 Balance, September 30, 2022 162,129,064 0.49 0.17 Balance, December 31, 2022 162,129,064 $ 0.49 $ 0.17 Issued 51,633,727 0.15 0.05 Expired (58,284,148 ) 0.50 0.27 Exercised (10,416,667 ) 0.11 0.12 Balance, September 30, 2023 145,061,976 $ 0.37 $ 0.09 |
Schedule of Warrants Outstanding Exercise Price | At September 30, 2023, the following warrants were outstanding: Schedule of Warrants Outstanding Exercise Price Exercise Number of Number of warrants Expiry date price (C$) warrants exercisable April 1, 2025 0.37 40,538,969 40,538,969 December 31, 2025 0.59 32,895,200 32,895,200 February 9, 2026 0.60 17,112,500 17,112,500 February 16, 2026 0.60 2,881,580 2,881,580 March 27, 2026 0.15 51,633,727 51,633,727 145,061,976 145,061,976 |
Schedule of Compensation Options | At September 30, 2023, the following broker options were outstanding: Schedule of Compensation Options Weighted Number of average broker exercise price options (C$) Balance, December 31, 2021 3,590,907 0.35 Issued – April 2022 Compensation Options (i) 1,879,892 0.30 Balance, December 31, 2022 5,470,799 $ 0.34 Issued – March 2023 Compensation Options (ii) 2,070,258 0.15 Expired – August 2020 Compensation Options (3,239,907 ) 0.35 Balance, September 30, 2023 4,301,150 0.24 (i) The grant date fair value of the April 2022 Compensation Options were estimated at $ 264,435 |
Schedule of Estimated Using Black-Scholes Valuation Model for Fair Value of Broker Options | Schedule of Estimated Using Black-Scholes Valuation Model for Fair Value of Broker Options Grant Date Risk free interest rate Dividend yield Volatility Stock price Weighted average life April 2022 2.34 % 0 % 120 % C$ 0.30 2 years (ii) The grant date fair value of the March 2023 Compensation Options were estimated at $ 111,971 Grant Date Risk free interest rate Dividend yield Volatility Stock price Weighted average life March 2023 3.4 % 0 % 120 % C$ 0.11 3 years |
Schedule of Broker Exercise Prices | Schedule of Broker Exercise Prices Exercise Number of Grant date Fair value Expiry date price (C$) broker options ($) February 16, 2024 (i) $ 0.40 351,000 $ 68,078 April 1, 2024 (ii) $ 0.30 1,879,892 $ 264,435 March 27, 2026 (iii) $ 0.15 2,070,258 $ 111,971 4,301,150 $ 444,484 i) Exercisable into one February 2021 Unit ii) Exercisable into one April 2022 Unit iii) Exercisable into one March 2023 Unit |
Schedule of Stock Options | The following table summarizes the stock option activity during the nine months ended September 30, 2023: Schedule of Stock Options Weighted average Number of exercise price stock options (C$) Balance, December 31, 2021 9,053,136 $ 0.58 Granted (i) 700,000 $ 0.15 Expired, May 1, 2022 (47,000 ) $ 10.00 Forfeited (150,000 ) $ 0.15 Expired, December 31, 2022 (235,500 ) $ 0.50 Balance, December 31, 2022 9,320,636 $ 0.51 Expired, September 30, 2023 (200,000 ) $ 0.60 Balance, September 30, 2023 9,120,636 $ 0.51 |
Schedule of Actual Stock Options Issued and Outstanding | The following table reflects the actual stock options issued and outstanding as of September 30, 2023: Schedule of Actual Stock Options Issued and Outstanding Number of remaining Number of options Grant date Exercise contractual options vested fair value price (C$) life (years) outstanding (exercisable) ($) 0.60 1.07 1,575,000 1,575,000 435,069 0.55 1.56 5,957,659 4,468,245 1,536,764 0.335 2.39 1,037,977 1,037,977 204,213 0.15 0.15 150,000 150,000 14,465 0.15 4.15 400,000 200,000 37,387 9,120,636 7,431,222 $ 2,227,898 |
Restricted Share Units (Tables)
Restricted Share Units (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Schedule of Restricted Share Units | The following table summarizes the RSU activity during the nine months ended September 30, 2023: Schedule of Restricted Share Units Weighted average grant date fair value Number of per share shares (C$) Unvested as at December 31, 2021 576,000 $ 0.62 Granted 6,620,641 0.17 Vested (2,373,900 ) 0.18 Unvested as at December 31, 2022 4,822,741 $ 0.22 Granted 10,844,993 0.23 Vested (5,767,218 ) 0.24 Unvested as at September 30, 2023 9,900,516 $ 0.22 (i) On January 10, 2022, the Company granted 500,000 122,249 (ii) On April 29, 2022, the Company granted 76,750 16,800 (iii) On June 30, 2022, the Company granted 15,000 2,328 (iv) On September 29, 2022 the Company granted 33,000 RSUs to two consultants of the Company, vesting immediately. The vesting of these RSUs resulted in stock-based compensation of $ 2,889 for the nine months ended September 30, 2022, which is included in operation and administration expenses on the unaudited condensed interim consolidated statements of income (loss) and comprehensive (loss) income. (v) On June 1, 2023, the Company granted 4,067,637 322,905 (vi) On June 4, 2023, the Company granted 42,000 7,825 (vii) On July 4, 2023, the Company granted 6,735,356 214,897 |
Deferred Share Units (Tables)
Deferred Share Units (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Deferred Share Units | |
Schedule of Deferred Share Units | The following table summarizes the DSU activity during the nine months ended September 30, 2023 and 2022: Schedule of Deferred Share Units Weighted average grant date fair value Number of per share shares (C$) Unvested as at December 31, 2021 5,625,000 $ 1.03 Vested (i) (3,125,000 ) 1.03 Unvested as at December 31, 2022 2,710,000 0.97 Granted (ii, iii) 1,857,280 0.23 Vested (iv, v) (3,071,826 ) 0.55 Unvested as at September 30, 2023 1,495,454 $ 0.90 (i) On March 31, 2022, the Board approved the early vesting of 625,000 2,500,000 750,000 375,000 0.30 (ii) On July 4, 2023, 1,611,826 (iii) On July 6, 2023, 245,454 (iv) On April 21, 2023, 1,250,000 (v) On July 1, 2023, 210,000 |
Related party transactions (Tab
Related party transactions (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Related Party Transactions [Abstract] | |
Schedule of Related Party Transactions | The Company’s key management personnel have the authority and responsibility for planning, directing and controlling the activities of the Company and consists of the Company’s executive management team and management directors. Schedule of Related Party Transactions Three Months Three Months Nine Months Nine Months September 30, September 30, September 30, September 30, 2023 2022 2023 2022 Consulting fees & wages $ 225,061 $ 248,472 $ 797,978 $ 1,832,323 |
Nature and Continuance of Ope_2
Nature and Continuance of Operations (Details Narrative) | 9 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Entity incorporation, state or country code | NV |
Schedule of Accounts receivable
Schedule of Accounts receivable and prepaid expenses (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Credit Loss [Abstract] | ||
Prepaid expenses and deposits | $ 595,318 | $ 386,218 |
Environment protection agency overpayment (note 6) | 90,000 | 170,729 |
Total | $ 685,318 | $ 556,947 |
Schedule of Equipment (Details)
Schedule of Equipment (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Property, Plant and Equipment [Abstract] | ||
Equipment, gross | $ 1,140,324 | $ 920,571 |
Less accumulated depreciation | (476,136) | (369,367) |
Equipment, net | $ 664,188 | $ 551,204 |
Schedule of Plant Asset Consist
Schedule of Plant Asset Consists (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Property, Plant and Equipment [Abstract] | ||
Plant purchase price less inventory | $ 3,633,292 | $ 3,633,292 |
Ball mill purchase | 745,626 | |
Demobilization | 2,204,539 | 2,201,414 |
Site preparation costs | 6,967,036 | 2,296,266 |
Process Plant | $ 13,550,493 | $ 8,130,972 |
Schedule of Right-of-use Asset
Schedule of Right-of-use Asset (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Property, Plant and Equipment [Abstract] | ||
Loader leases | $ 163,205 | |
Loader leases accumulated depreciation | (19,656) | |
Right-of-use asset, net | $ 143,549 |
Equipment, Right-of-Use asset_3
Equipment, Right-of-Use asset, and Process Plant (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | |||||
Jun. 30, 2023 | May 13, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Jan. 07, 2022 | |
Property, Plant and Equipment [Line Items] | |||||||
Depreciation expenses | $ 126,425 | $ 172,259 | |||||
Cash remitted | 219,751 | 316,600 | |||||
Value of warrants issued | 488,357 | (18,538,380) | |||||
Payments for deposits | 19,000,000 | ||||||
Depreciation expenses lease | $ 6,887 | 19,656 | 52,353 | ||||
Ball Mill [Member] | |||||||
Property, Plant and Equipment [Line Items] | |||||||
Purchase payments | $ 745,626 | ||||||
Teck Resources Limited [Member] | |||||||
Property, Plant and Equipment [Line Items] | |||||||
Non-refundable deposit | $ 500,000 | ||||||
Sales tax paid | $ 231,000 | ||||||
Cash remitted | 731,000 | ||||||
Value of shares issued | $ 1,970,264 | ||||||
Value of warrants issued | 1,273,032 | ||||||
Total value | 3,974,296 | ||||||
Spare parts inventory | 341,004 | 341,004 | |||||
D'Angelo International LLC [Member] | |||||||
Property, Plant and Equipment [Line Items] | |||||||
Purchase payments | 545,626 | ||||||
Payments for deposits | $ 100,000 | ||||||
Equipment [Member] | |||||||
Property, Plant and Equipment [Line Items] | |||||||
Depreciation expenses | $ 30,344 | $ 42,814 | $ 106,769 | $ 119,905 |
Schedule of Mining Interests (D
Schedule of Mining Interests (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Extractive Industries [Abstract] | ||
Bunker Hill Mine purchase | $ 14,247,210 | $ 14,247,210 |
Capitalized development | 2,218,440 | 1,447,435 |
Sale of mineral properties (note 7) | (1,973,840) | |
Bunker Hill mine | $ 14,491,810 | $ 15,694,645 |
Bunker Hill Mine and Mining I_3
Bunker Hill Mine and Mining Interests (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | |||||||||
Jun. 23, 2023 | Mar. 03, 2022 | Jan. 07, 2022 | Nov. 20, 2020 | Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | Jan. 08, 2022 | Jan. 06, 2022 | |
Reserve Quantities [Line Items] | |||||||||||
Payments for deposits | $ 19,000,000 | ||||||||||
Mine at time of purchase | $ 14,247,210 | 14,247,210 | $ 14,247,210 | ||||||||
Gain on extinguishment of debt | 99,569 | ||||||||||
Land purchase | $ 202,000 | $ 202,000 | |||||||||
Monthly payments | 10,000 | ||||||||||
C and E Tree Farm LLC [Member] | Through February 2026 [Member] | |||||||||||
Reserve Quantities [Line Items] | |||||||||||
Monthly payments | 10,000 | ||||||||||
C and E Tree Farm LLC [Member] | Through March 1, 2026 [Member] | |||||||||||
Reserve Quantities [Line Items] | |||||||||||
Option to purchase land | 3,129,500 | 3,129,500 | |||||||||
Royalty Convertible Debenture [Member] | |||||||||||
Reserve Quantities [Line Items] | |||||||||||
Capitalized cost | 1.85% | ||||||||||
RCD Note [Member] | |||||||||||
Reserve Quantities [Line Items] | |||||||||||
Capitalized cost | 1.85% | ||||||||||
Gain on extinguishment of debt | $ 6,980,932 | ||||||||||
Mine Development [Member] | |||||||||||
Reserve Quantities [Line Items] | |||||||||||
Capitalized cost | $ 2,218,439 | ||||||||||
Amended Agreement [Member], Placer Mining Corp [Member] | |||||||||||
Reserve Quantities [Line Items] | |||||||||||
Purchases price consideration | $ 7,700,000 | ||||||||||
Payable in cash | 5,700,000 | ||||||||||
Remaining payments purchase assets | 300,000 | ||||||||||
Consideration shares | 2,000,000 | ||||||||||
Contract purchase price | 2,000,000 | ||||||||||
Amended Agreement [Member], Placer Mining Corp [Member] | Minimum [Member] | |||||||||||
Reserve Quantities [Line Items] | |||||||||||
Payable in cash | 3,400,000 | ||||||||||
Number shares issued of common shares | 2,000,000 | ||||||||||
E P A Settlement Agreement Member Placer Mining Corp [Member] | |||||||||||
Reserve Quantities [Line Items] | |||||||||||
Payable in cash | 5,400,000 | ||||||||||
Contract purchase price | 7,700,000 | ||||||||||
EPA cost recovery payable - short-term | $ 11,000,000 | ||||||||||
Payments for deposits | 2,000,000 | ||||||||||
Credit by seller for prior maintenance payments | 300,000 | ||||||||||
Net present value of water treatment cost recovery liability assumed | 6,402,425 | ||||||||||
Capitalized legal and closing costs | 444,785 | ||||||||||
Mine at time of purchase | 14,247,210 | ||||||||||
Environmental Protection Agency Agreement [Member] | |||||||||||
Reserve Quantities [Line Items] | |||||||||||
Payable in cash | 5,400,000 | ||||||||||
Payments purchase asset | 3,400,000 | ||||||||||
Incremental Liabilities | 8,000,000 | $ 17,000,000 | $ 17,000,000 | $ 9,000,000 | $ 8,000,000 | ||||||
Environmental Protection Agency Agreement [Member] | Common Stock [Member] | |||||||||||
Reserve Quantities [Line Items] | |||||||||||
Remaining payments purchase assets | $ 2,000,000 |
Schedule of Amended Settlement
Schedule of Amended Settlement Environmental Protection Agency Agreement (Details) - Environmental Protection Agency Agreement [Member] | Sep. 30, 2023 USD ($) |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Within 30 days of Settlement Agreement | $ 2,000,000 |
November 1, 2024 | 3,000,000 |
November 1, 2025 | 3,000,000 |
November 1, 2026 | 3,000,000 |
November 1, 2027 | 3,000,000 |
November 1, 2028 | 3,000,000 |
November 1, 2029 | $ 2,000,000 |
Environmental Protection Agen_3
Environmental Protection Agency and Water Treatment Liabilities (“EPA”) (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||
Jan. 07, 2022 | Sep. 30, 2023 | Sep. 30, 2023 | Dec. 31, 2022 | Sep. 30, 2022 | Jan. 08, 2022 | Jan. 06, 2022 | |
Payments for Deposits | $ 19,000,000 | ||||||
Liabilities current | $ 5,122,137 | 5,122,137 | $ 10,155,582 | ||||
Monthly fee | 20,000 | ||||||
Restricted cash | 6,476,000 | 6,476,000 | 6,476,000 | $ 9,476,000 | |||
Discount amortization expense | 420,518 | 1,191,487 | |||||
Environment protection agency cost recovery liability, net of discount | 9,132,953 | 9,132,953 | |||||
Interest payable | 154,743 | 154,743 | |||||
Monthly instalments | 100,000 | 100,000 | |||||
Monthly costs water treatment charges | 100,000 | ||||||
Prepaid expense | 90,000 | 90,000 | 170,729 | ||||
Third Party [Member] | |||||||
Payment bond | 4,475,000 | ||||||
Bunker Hill Mine [Member] | |||||||
Capitalized carring value | 6,402,425 | 6,402,425 | |||||
Liabilities current | 3,000,000 | 3,000,000 | |||||
Liabilities non current | 5,000,000 | 5,000,000 | |||||
Discount purchase price | 3,402,425 | ||||||
EPA Settlement Agreement Amendment [Member] | |||||||
Payment bond | 17,000,000 | ||||||
Payment to amended settlement | $ 17,000,000 | ||||||
Letter of credit | 2,001,000 | 2,001,000 | |||||
Secured deposits | 6,476,000 | 6,476,000 | |||||
EPA Settlement Agreement Amendment [Member] | Payment Bond One [Member] | |||||||
Payment bond | 9,999,000 | ||||||
EPA Settlement Agreement Amendment [Member] | Payment Bond Two [Member] | |||||||
Payment bond | 5,000,000 | ||||||
Environmental Protection Agency Agreement [Member] | |||||||
Discount on debt | $ 8,000,000 | $ 17,000,000 | $ 17,000,000 | $ 9,000,000 | $ 8,000,000 | ||
Environmental Protection Agency Agreement [Member] | Common Stock [Member] | |||||||
Remaining payments purchase assets | $ 2,000,000 |
Schedule of Key Valuation Input
Schedule of Key Valuation Inputs (Details) | 9 Months Ended | |
Sep. 30, 2023 $ / shares | [1],[2],[4] | |
C D One Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Valuation date | Dec. 31, 2022 | [3] |
Maturity date | Mar. 31, 2025 | [3] |
Share price | $ 0.125 | [3] |
RCD Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Valuation date | Dec. 31, 2022 | |
Maturity date | Mar. 31, 2025 | |
Share price | $ 0.125 | |
CD2 Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Valuation date | Dec. 31, 2022 | [3] |
Maturity date | Mar. 31, 2025 | [3] |
Share price | $ 0.125 | [3] |
CD One Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Valuation date | Mar. 31, 2023 | [3] |
Maturity date | Mar. 31, 2025 | [3] |
Share price | $ 0.082 | [3] |
RCD Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Valuation date | Mar. 31, 2023 | |
Maturity date | Mar. 31, 2025 | |
Share price | $ 0.082 | |
CD2 Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Valuation date | Mar. 31, 2023 | [3] |
Maturity date | Mar. 31, 2025 | [3] |
Share price | $ 0.082 | [3] |
RCD Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Valuation date | Jun. 23, 2023 | |
Maturity date | Mar. 31, 2025 | |
Share price | $ 0.169 | |
CD One Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Valuation date | Jun. 30, 2023 | [3] |
Maturity date | Mar. 31, 2026 | [3] |
Share price | $ 0.186 | [3] |
CD Two Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Valuation date | Jun. 30, 2023 | [3] |
Maturity date | Mar. 31, 2026 | [3] |
Share price | $ 0.186 | [3] |
CD One Note Four [Member] | ||
Short-Term Debt [Line Items] | ||
Valuation date | Sep. 30, 2023 | [3] |
Maturity date | Mar. 31, 2026 | [3] |
Share price | $ 0.104 | [3] |
CD Two Note Four [Member] | ||
Short-Term Debt [Line Items] | ||
Valuation date | Sep. 30, 2023 | [3] |
Maturity date | Mar. 31, 2026 | [3] |
Share price | $ 0.104 | [3] |
Measurement Input Contractual Interest Rate [Member] | C D One Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 7.50 | [3] |
Measurement Input Contractual Interest Rate [Member] | RCD Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 9 | |
Measurement Input Contractual Interest Rate [Member] | CD2 Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 10.50 | [3] |
Measurement Input Contractual Interest Rate [Member] | CD One Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 7.50 | [3] |
Measurement Input Contractual Interest Rate [Member] | RCD Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 9 | |
Measurement Input Contractual Interest Rate [Member] | CD2 Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 10.50 | [3] |
Measurement Input Contractual Interest Rate [Member] | RCD Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 9 | |
Measurement Input Contractual Interest Rate [Member] | CD One Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 7.50 | [3] |
Measurement Input Contractual Interest Rate [Member] | CD Two Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 10.50 | [3] |
Measurement Input Contractual Interest Rate [Member] | CD One Note Four [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 7.50 | [3] |
Measurement Input Contractual Interest Rate [Member] | CD Two Note Four [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 10.50 | [3] |
Measurement Input, Option Volatility [Member] | C D One Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 120 | [3] |
Measurement Input, Option Volatility [Member] | RCD Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 120 | |
Measurement Input, Option Volatility [Member] | CD2 Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 120 | [3] |
Measurement Input, Option Volatility [Member] | CD One Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 115 | [3] |
Measurement Input, Option Volatility [Member] | RCD Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 115 | |
Measurement Input, Option Volatility [Member] | CD2 Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 115 | [3] |
Measurement Input, Option Volatility [Member] | RCD Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 120 | |
Measurement Input, Option Volatility [Member] | CD One Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 120 | [3] |
Measurement Input, Option Volatility [Member] | CD Two Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 120 | [3] |
Measurement Input, Option Volatility [Member] | CD One Note Four [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 115 | [3] |
Measurement Input, Option Volatility [Member] | CD Two Note Four [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 115 | [3] |
Measurement Input, Credit Spread [Member] | C D One Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 7.08 | [3] |
Measurement Input, Credit Spread [Member] | RCD Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 7.08 | |
Measurement Input, Credit Spread [Member] | CD2 Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 7.08 | [3] |
Measurement Input, Credit Spread [Member] | CD One Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 11.22 | [3] |
Measurement Input, Credit Spread [Member] | RCD Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 11.22 | |
Measurement Input, Credit Spread [Member] | CD2 Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 11.22 | [3] |
Measurement Input, Credit Spread [Member] | RCD Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 8.28 | |
Measurement Input, Credit Spread [Member] | CD One Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 7.93 | [3] |
Measurement Input, Credit Spread [Member] | CD Two Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 7.93 | [3] |
Measurement Input, Credit Spread [Member] | CD One Note Four [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 8.65 | [3] |
Measurement Input, Credit Spread [Member] | CD Two Note Four [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 8.65 | [3] |
Measurement Input, Risk Free Interest Rate [Member] | C D One Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 4.32 | [3] |
Measurement Input, Risk Free Interest Rate [Member] | RCD Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 4.32 | |
Measurement Input, Risk Free Interest Rate [Member] | CD2 Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 4.32 | [3] |
Measurement Input, Risk Free Interest Rate [Member] | CD One Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 4.06 | [3] |
Measurement Input, Risk Free Interest Rate [Member] | RCD Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 4.06 | |
Measurement Input, Risk Free Interest Rate [Member] | CD2 Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 4.06 | [3] |
Measurement Input, Risk Free Interest Rate [Member] | RCD Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 4.83 | |
Measurement Input, Risk Free Interest Rate [Member] | CD One Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 4.58 | [3] |
Measurement Input, Risk Free Interest Rate [Member] | CD Two Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 4.58 | [3] |
Measurement Input, Risk Free Interest Rate [Member] | CD One Note Four [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 4.91 | [3] |
Measurement Input, Risk Free Interest Rate [Member] | CD Two Note Four [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 4.91 | [3] |
Measurement Input Risk Adjusted Rate [Member] | C D One Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 17.85 | [3] |
Measurement Input Risk Adjusted Rate [Member] | RCD Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 17.85 | |
Measurement Input Risk Adjusted Rate [Member] | CD2 Note One [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 19.76 | [3] |
Measurement Input Risk Adjusted Rate [Member] | CD One Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 21.33 | [3] |
Measurement Input Risk Adjusted Rate [Member] | RCD Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 21.33 | |
Measurement Input Risk Adjusted Rate [Member] | CD2 Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 23.20 | [3] |
Measurement Input Risk Adjusted Rate [Member] | RCD Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 19.37 | |
Measurement Input Risk Adjusted Rate [Member] | CD One Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 18.83 | [3] |
Measurement Input Risk Adjusted Rate [Member] | CD Two Note Three [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 20.73 | [3] |
Measurement Input Risk Adjusted Rate [Member] | CD One Note Four [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 19.78 | [3] |
Measurement Input Risk Adjusted Rate [Member] | CD Two Note Four [Member] | ||
Short-Term Debt [Line Items] | ||
Convertible Debenture | 21.67 | [3] |
[1]A project risk rate of 13.0 7.23 9.32 0.219 0.226 0.219 0.212 1.85 1.85 77 |
Schedule of Key Valuation Inp_2
Schedule of Key Valuation Inputs (Details) (Parenthetical) | Sep. 30, 2023 $ / shares | Dec. 31, 2022 $ / shares |
CD1 Note [Member] | ||
Short-Term Debt [Line Items] | ||
RCD2 | 5 | |
Conversion price | $ 0.219 | $ 0.219 |
CD2 Note [Member] | ||
Short-Term Debt [Line Items] | ||
RCD2 | 10 | |
CD2 Note [Member] | Measurement Input, Credit Spread [Member] | ||
Short-Term Debt [Line Items] | ||
RCD2 | 9.32 | |
CD1 and RCD [Member] | Measurement Input, Credit Spread [Member] | ||
Short-Term Debt [Line Items] | ||
RCD2 | 7.23 | |
CD1 Note Two [Member] | ||
Short-Term Debt [Line Items] | ||
Conversion price | $ 0.226 | $ 0.212 |
RCD Note [Member] | ||
Short-Term Debt [Line Items] | ||
Percentage of royalty revenue | 1.85% | |
RCD Note [Member] | Measurement Input Project Risk Rate [Member] | ||
Short-Term Debt [Line Items] | ||
RCD2 | 13 | |
RCD Note [Member] | Measurement Input, Option Volatility [Member] | ||
Short-Term Debt [Line Items] | ||
RCD2 | 77 |
Schedule of Fair Value Derivati
Schedule of Fair Value Derivative Liability (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Short-Term Debt [Line Items] | ||
Total Fair Value | $ 17,936,793 | $ 29,886,662 |
CD1 Note [Member] | ||
Short-Term Debt [Line Items] | ||
Total Fair Value | 5,190,551 | 5,537,360 |
RCD Note [Member] | ||
Short-Term Debt [Line Items] | ||
Total Fair Value | 10,285,777 | |
CD2 Note [Member] | ||
Short-Term Debt [Line Items] | ||
Total Fair Value | $ 12,746,242 | $ 14,063,525 |
Promissory Notes Payable and _3
Promissory Notes Payable and Convertible Debentures (Details Narrative) | 1 Months Ended | 3 Months Ended | 9 Months Ended | ||||||||||||||
Jun. 23, 2023 USD ($) | Feb. 21, 2023 USD ($) | Dec. 06, 2022 USD ($) | Jun. 17, 2022 USD ($) $ / shares | Mar. 03, 2022 USD ($) | Jan. 28, 2022 USD ($) | Jan. 07, 2022 USD ($) | Dec. 20, 2021 USD ($) | Sep. 22, 2021 USD ($) | Jun. 30, 2023 USD ($) | Jun. 30, 2022 USD ($) | Sep. 30, 2023 USD ($) $ / shares shares | Sep. 30, 2022 USD ($) | Sep. 30, 2023 USD ($) $ / shares shares | Sep. 30, 2022 USD ($) shares | Dec. 31, 2022 USD ($) $ / shares | Jan. 28, 2022 $ / shares | |
Short-Term Debt [Line Items] | |||||||||||||||||
Interest rate | 15% | 15% | |||||||||||||||
Debt face amount | $ 21,000,000 | ||||||||||||||||
Gain on extinguishment of debt | $ 99,569 | ||||||||||||||||
Convertible debt | $ 66,000,000 | ||||||||||||||||
Notes payable current | 1,095,253 | 1,095,253 | $ 1,500,000 | ||||||||||||||
Interest expense | 2,143,840 | ||||||||||||||||
Project finance package convertible debenture | $ 50,000,000 | ||||||||||||||||
Project financing fee | 51,000,000 | ||||||||||||||||
Project finance package amount | 67,000,000 | ||||||||||||||||
Debt amount available under stream | 46,000,000 | ||||||||||||||||
Previously proposed | 37,000,000 | ||||||||||||||||
Gross proceeds received | 9,000,000 | ||||||||||||||||
Payments of Financing Costs | 254,220 | ||||||||||||||||
Proceeds from Lines of Credit | 21,000,000 | ||||||||||||||||
Gain on fv of debenture | 347,499 | $ 2,450,968 | 1,301,069 | $ 2,256,437 | 3,041,056 | ||||||||||||
Royalty expense | $ 8,000,000 | ||||||||||||||||
Interest rate | 11.40% | 11.40% | |||||||||||||||
[custom:GainOnFairValueOfConvertibleDebtDerivatives] | $ 2,450,968 | 1,301,069 | $ 2,256,437 | 3,041,056 | |||||||||||||
Loss on debt settlement | (268,889) | ||||||||||||||||
Loss on debt settlement | 268,889 | ||||||||||||||||
Gains loss on extinguishment debt | (99,569) | ||||||||||||||||
Interest expense, debt | 2,293,643 | 1,026,233 | 5,006,692 | 2,143,840 | |||||||||||||
Funding stream description | On June 23, 2023, all conditions were met for the closing of the Stream, and $46,000,000 was advanced to the Company. The Stream applies to 10% of all payable metals sold until a minimum quantity of metal is delivered consisting of, individually, 63.5 million pounds of zinc, 40.4 million pounds of lead, and 1.2 million ounces of silver (subsequently amended, as described below). Thereafter, the Stream would apply to 2% of payable metals sold. The delivery price of streamed metals will be 20% of the applicable spot price. The Company may buy back 50% of the Stream Amount at a 1.40x multiple of the Stream Amount between the second and third anniversary of the date of funding, and at a 1.65x multiple of the Stream Amount between the third and fourth anniversary of the date of funding. | ||||||||||||||||
Debt instrument transaction cost | $ 824,156 | ||||||||||||||||
Stream debenture non current | $ 45,175,844 | 46,665,044 | 46,665,044 | ||||||||||||||
Other expenses | $ 1,321,000 | 0 | $ 1,406,000 | $ 0 | |||||||||||||
Common Stock [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Issuance of shares | shares | 0 | 20,125,209 | 3,291,339 | ||||||||||||||
Other Comprehensive Income (Loss) [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
[custom:GainOnFairValueOfConvertibleDebtDerivatives] | $ 68,738 | 625,050 | $ 502,335 | $ 996,636 | |||||||||||||
Consolidated Balance Sheets [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Interest expense | 510,411 | 691,111 | 1,857,822 | 1,279,849 | |||||||||||||
Interest payable current | 510,411 | 510,411 | 691,890 | ||||||||||||||
Convertible Debt [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Maturity date | Jun. 23, 2027 | ||||||||||||||||
Debt face amount | $ 21,000,000 | $ 15,000,000 | $ 6,000,000 | ||||||||||||||
Convertible debt | 37,000,000 | ||||||||||||||||
Debt advance payment | $ 5,000,000 | ||||||||||||||||
Increase in debt | $ 5,000,000 | ||||||||||||||||
Maturity date, description | maturity date would be amended from July 7, 2023 to March 31, 2025 | ||||||||||||||||
Interest rate | 10% | 10.50% | 7.50% | ||||||||||||||
Common shares price | (per share) | $ 0.0029 | $ 0.30 | |||||||||||||||
Debt description | The maturity date of any drawings under the Debt Facility will be June 23, 2027. For every $5 million or part thereof advanced under the Debt Facility, the Company will grant a new 0.5% life-of-mine gross revenue royalty, on the same terms as the Royalty, to a maximum of 2.0% on the Primary Claims and 1.4% on the Secondary Claims. The Company may buy back 50% of these royalties for $20 million. The Company determined that no recognition is required on the financial statements as of September 30, 2023 as no amount has been drawn from the facility. | ||||||||||||||||
Debt term | 2 years | ||||||||||||||||
Royalties payment | $ 20,000,000 | ||||||||||||||||
Convertible Debt [Member] | 3 Quartely Payments Beginning June 30, 2024 [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Debt advance payment | $ 2,000,000 | ||||||||||||||||
Convertible Debt [Member] | Maturity Date [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Debt advance payment | 9,000,000 | ||||||||||||||||
Bridge Loan [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Debt face amount | $ 5,000,000 | ||||||||||||||||
Gain on extinguishment of debt | (222,754) | ||||||||||||||||
Debt description | The Bridge Loan bears interest at 10.5% per annum and matures at the earlier of (i) the advance of the Stream, or (ii) June 30, 2024. In addition, the minimum quantity of metal delivered under the Stream, if advanced, would increase by 5% relative to amounts previously announced. | ||||||||||||||||
Increase in quantity delivered | 5% | ||||||||||||||||
Gains loss on extinguishment debt | 222,754 | ||||||||||||||||
Bridge Loan [Member] | Consolidated Balance Sheets [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Interest payable current | 53,985 | ||||||||||||||||
Interest expense, debt | 168,166 | 346,550 | |||||||||||||||
Multi-metal Stream [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Convertible debt | 37,000,000 | ||||||||||||||||
Non Convertible Promissory Notes Payable [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Notes payable | $ 2,500,000 | ||||||||||||||||
Interest rate | 15% | 10% | |||||||||||||||
Payments to acquire land held for use | $ 202,000 | ||||||||||||||||
Maturity date | Dec. 31, 2023 | ||||||||||||||||
Debt face amount | 504,315 | 504,315 | 1,000,000 | ||||||||||||||
Gain on extinguishment of debt | 99,569 | ||||||||||||||||
Convertible debt | $ 150,000 | ||||||||||||||||
Debt advance payment | $ 18,000 | $ 15,000 | |||||||||||||||
Notes payable current | 1,095,253 | 1,095,253 | |||||||||||||||
Interest expense | 41,410 | $ 56,712 | 151,821 | $ 224,589 | |||||||||||||
Deferred finance costs current | $ 44,560 | 44,560 | $ 384,041 | ||||||||||||||
Gains loss on extinguishment debt | $ (99,569) | ||||||||||||||||
Non Convertible Promissory Notes Payable [Member] | Related Party [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Convertible debt | 120,000 | ||||||||||||||||
Non Convertible Promissory Notes Payable [Member] | Another Party [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Convertible debt | $ 120,000 | ||||||||||||||||
RCD Note [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Interest rate | 9% | ||||||||||||||||
Debt face amount | $ 8,000,000 | ||||||||||||||||
Gain on extinguishment of debt | 6,980,932 | ||||||||||||||||
Convertible debt | 96,000,000 | 8,000,000 | $ 8,000,000 | ||||||||||||||
Royalty percentage | 1.85% | ||||||||||||||||
Maturity date, description | maturity date from July 7, 2023 to March 31, 2025. | ||||||||||||||||
Gains loss on extinguishment debt | (6,980,932) | ||||||||||||||||
CD1 Note [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Convertible debt | 5,000,000 | ||||||||||||||||
Increase in debt | $ 6,000,000 | ||||||||||||||||
Common shares price | $ / shares | $ 0.219 | $ 0.219 | $ 0.219 | ||||||||||||||
CD2 Note [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Convertible debt | $ 15,000,000 | ||||||||||||||||
CD One And CD Two Note [Member] | Minimum [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Debt advance payment | 6,000,000 | ||||||||||||||||
CD One And CD Two Note [Member] | Maximum [Member] | |||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||
Debt advance payment | $ 15,000,000 |
Schedule of Estimated Fair Valu
Schedule of Estimated Fair Value of Special Warrant Liabilities (Details) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||
Sep. 30, 2023 USD ($) | Sep. 30, 2022 USD ($) | Sep. 30, 2023 USD ($) | Sep. 30, 2022 USD ($) | Dec. 31, 2022 USD ($) | Sep. 30, 2023 $ / shares | Dec. 31, 2022 $ / shares | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Fair value | $ 488,357 | $ (18,538,380) | |||||
Change in derivative liability | $ 8,531,630 | $ 7,315,161 | (488,357) | 18,538,380 | |||
Common stock | 7,425,377 | $ 7,307,967 | |||||
March 2023 Special Warrants Issuance [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Expected life | 977 days | 1096 days | |||||
Share price | $ / shares | $ 0.15 | $ 0.11 | |||||
Fair value | 9,809,314 | $ 4,536,020 | |||||
Change in derivative liability | 5,273,294 | ||||||
Common stock | 7,425,377 | ||||||
Warrants | $ 2,383,937 | ||||||
March 2023 Special Warrants Issuance [Member] | Measurement Input, Option Volatility [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 24 | 24 | |||||
March 2023 Special Warrants Issuance [Member] | Measurement Input, Risk Free Interest Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 4.64 | 3.40 | |||||
March 2023 Special Warrants Issuance [Member] | Measurement Input, Expected Dividend Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 0 | 0 |
Schedule of Estimated Using the
Schedule of Estimated Using the Binomial Model to Determine the Fair Value of Warrant Liabilities (Details) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||
Sep. 30, 2023 USD ($) | Sep. 30, 2022 USD ($) | Sep. 30, 2023 USD ($) | Sep. 30, 2022 USD ($) | Dec. 31, 2022 USD ($) | Sep. 30, 2023 $ / shares | Dec. 31, 2022 $ / shares | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Fair value | $ 488,357 | $ (18,538,380) | |||||
Change in derivative liability | $ 8,531,630 | $ 7,315,161 | (488,357) | $ 18,538,380 | |||
Warrant [Member] | March Two Thousand Twenty Three Warrants [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Expected life | 909 days | 909 days | |||||
Share price | $ / shares | $ 0.15 | $ 0.19 | |||||
Fair value | 1,149,538 | $ 2,383,937 | |||||
Change in derivative liability | (1,234,399) | ||||||
Warrant [Member] | March Two Thousand Twenty Three Warrants [Member] | Measurement Input, Option Volatility [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 24 | 24 | |||||
Warrant [Member] | March Two Thousand Twenty Three Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 4.64 | 4.33 | |||||
Warrant [Member] | March Two Thousand Twenty Three Warrants [Member] | Measurement Input, Expected Dividend Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 0 | 0 | |||||
Special Warrant Issuance [Member] | April 2022 Issuance [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Expected life | 549 days | 822 days | |||||
Share price | $ / shares | $ 0.15 | $ 0.17 | |||||
Fair value | 1,408,152 | 2,406,104 | |||||
Change in derivative liability | (997,952) | ||||||
Special Warrant Issuance [Member] | April 2022 Issuance [Member] | Measurement Input, Option Volatility [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 120 | 120 | |||||
Special Warrant Issuance [Member] | April 2022 Issuance [Member] | Measurement Input, Risk Free Interest Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 4.87 | 4.06 | |||||
Special Warrant Issuance [Member] | April 2022 Issuance [Member] | Measurement Input, Expected Dividend Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 0 | 0 | |||||
Non Brokered Issuance [Member] | April 2022 Issuance [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Expected life | 549 days | 822 days | |||||
Share price | $ / shares | $ 0.15 | $ 0.17 | |||||
Fair value | 54,751 | 93,553 | |||||
Change in derivative liability | (38,802) | ||||||
Non Brokered Issuance [Member] | April 2022 Issuance [Member] | Measurement Input, Option Volatility [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 120 | 120 | |||||
Non Brokered Issuance [Member] | April 2022 Issuance [Member] | Measurement Input, Risk Free Interest Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 4.87 | 4.06 | |||||
Non Brokered Issuance [Member] | April 2022 Issuance [Member] | Measurement Input, Expected Dividend Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 0 | 0 | |||||
Warrant Liabilities [Member] | June 2022 Issuance [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Expected life | 549 days | 822 days | |||||
Share price | $ / shares | $ 0.15 | $ 0.17 | |||||
Fair value | 45,314 | 77,429 | |||||
Change in derivative liability | (32,115) | ||||||
Warrant Liabilities [Member] | June 2022 Issuance [Member] | Measurement Input, Option Volatility [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 120 | 120 | |||||
Warrant Liabilities [Member] | June 2022 Issuance [Member] | Measurement Input, Risk Free Interest Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 4.87 | 3.72 | |||||
Warrant Liabilities [Member] | June 2022 Issuance [Member] | Measurement Input, Expected Dividend Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 0 | 0 | |||||
Warrant Liabilities [Member] | February 2021 Issuance [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Expected life | 863 days | 1136 days | |||||
Share price | $ / shares | $ 0.15 | $ 0.17 | |||||
Fair value | 872,523 | 1,335,990 | |||||
Change in derivative liability | (463,467) | ||||||
Warrant Liabilities [Member] | February 2021 Issuance [Member] | Measurement Input, Option Volatility [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 120 | 120 | |||||
Warrant Liabilities [Member] | February 2021 Issuance [Member] | Measurement Input, Risk Free Interest Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 4.64 | 3.72 | |||||
Warrant Liabilities [Member] | February 2021 Issuance [Member] | Measurement Input, Expected Dividend Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 0 | 0 | |||||
Warrant Liabilities [Member] | August 2020 Issuance [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Expected life | 243 days | ||||||
Share price | $ / shares | $ 0.17 | ||||||
Fair value | 903,697 | ||||||
Change in derivative liability | (903,697) | ||||||
Expected life | Expired | ||||||
Warrant Liabilities [Member] | August 2020 Issuance [Member] | Measurement Input, Option Volatility [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 120 | ||||||
Warrant Liabilities [Member] | August 2020 Issuance [Member] | Measurement Input, Risk Free Interest Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 4.06 | ||||||
Warrant Liabilities [Member] | August 2020 Issuance [Member] | Measurement Input, Expected Dividend Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 0 | ||||||
Warrant Liabilities [Member] | June 2019 Issuance [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Expected life | 823 days | 1096 days | |||||
Share price | $ / shares | $ 0.15 | $ 0.17 | |||||
Fair value | 444,149 | 725,737 | |||||
Change in derivative liability | (281,588) | ||||||
Warrant Liabilities [Member] | June 2019 Issuance [Member] | Measurement Input, Option Volatility [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 115 | 120 | |||||
Warrant Liabilities [Member] | June 2019 Issuance [Member] | Measurement Input, Risk Free Interest Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 4.87 | 3.82 | |||||
Warrant Liabilities [Member] | June 2019 Issuance [Member] | Measurement Input, Expected Dividend Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 0 | 0 | |||||
Warrant Liabilities [Member] | August 2019 Issuance [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Expected life | 823 days | 1096 days | |||||
Share price | $ / shares | $ 0.15 | $ 0.17 | |||||
Fair value | 682,604 | $ 1,115,369 | |||||
Change in derivative liability | $ (432,765) | ||||||
Warrant Liabilities [Member] | August 2019 Issuance [Member] | Measurement Input, Option Volatility [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 115 | 120 | |||||
Warrant Liabilities [Member] | August 2019 Issuance [Member] | Measurement Input, Risk Free Interest Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 4.87 | 3.82 | |||||
Warrant Liabilities [Member] | August 2019 Issuance [Member] | Measurement Input, Expected Dividend Rate [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Warrants and right measurement input | 0 | 0 |
Schedule of Warrant Activity (D
Schedule of Warrant Activity (Details) - Warrant [Member] | 9 Months Ended | |||
Sep. 30, 2023 $ / shares shares | Sep. 30, 2023 $ / shares shares | Sep. 30, 2022 $ / shares shares | Sep. 30, 2022 $ / shares shares | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Number of warrants, beginning balance | shares | 162,129,064 | 162,129,064 | 111,412,712 | 111,412,712 |
Weighted average exercise price, beginning balance | $ 0.49 | $ 0.54 | ||
Weighted average grant date, beginning balance | $ 0.17 | $ 0.18 | ||
Number of warrants, issued | shares | 51,633,727 | 51,633,727 | 50,955,636 | 50,955,636 |
Weighted average issued price, Issued | $ 0.15 | $ 0.37 | ||
Weighted average grant date, Issued | $ 0.05 | $ 0.15 | ||
Number of warrants, Expired | shares | (58,284,148) | (58,284,148) | (239,284) | (239,284) |
Weighted average exercise price, Expired | $ 0.50 | $ 0.70 | ||
Weighted average grant date, Expired | $ 0.27 | $ 0.21 | ||
Number of warrants, ending balance | shares | 145,061,976 | 145,061,976 | 162,129,064 | 162,129,064 |
Weighted average exercise price, ending balance | $ 0.37 | $ 0.49 | ||
Weighted average grant date, ending balance | $ 0.09 | $ 0.17 | ||
Number of warrants, Exercised | shares | (10,416,667) | (10,416,667) | ||
Weighted average exercise price, Exercised | $ 0.11 | |||
Weighted average grant date, Expired | $ 0.12 |
Schedule of Warrants Outstandin
Schedule of Warrants Outstanding Exercise Price (Details) | Sep. 30, 2023 $ / shares shares |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |
Number of warrants | 145,061,976 |
Number of warrants exercisable | 145,061,976 |
Warrants One [Member] | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |
Expiry date | Apr. 01, 2025 |
Exercise price | $ / shares | $ 0.37 |
Number of warrants | 40,538,969 |
Number of warrants exercisable | 40,538,969 |
Warrants Two [Member] | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |
Expiry date | Dec. 31, 2025 |
Exercise price | $ / shares | $ 0.59 |
Number of warrants | 32,895,200 |
Number of warrants exercisable | 32,895,200 |
Warrants Three [Member] | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |
Expiry date | Feb. 09, 2026 |
Exercise price | $ / shares | $ 0.60 |
Number of warrants | 17,112,500 |
Number of warrants exercisable | 17,112,500 |
Warrants Four [Member] | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |
Expiry date | Feb. 16, 2026 |
Exercise price | $ / shares | $ 0.60 |
Number of warrants | 2,881,580 |
Number of warrants exercisable | 2,881,580 |
Warrants Five [Member] | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |
Expiry date | Mar. 27, 2026 |
Exercise price | $ / shares | $ 0.15 |
Number of warrants | 51,633,727 |
Number of warrants exercisable | 51,633,727 |
Schedule of Compensation Option
Schedule of Compensation Options (Details) | 3 Months Ended | 4 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2023 $ / shares shares | May 01, 2022 $ / shares shares | Sep. 30, 2023 USD ($) shares | Sep. 30, 2023 $ / shares | Dec. 31, 2022 $ / shares shares | ||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
Number of stock options, beginning | shares | 9,053,136 | 9,320,636 | 9,053,136 | |||
Weighted average exercise price beginning balance | $ / shares | $ 0.58 | $ 0.51 | $ 0.58 | |||
Issued - Compensation Options | shares | [1] | 700,000 | ||||
Weighted Average exercise price, Compensation Options Issued | $ / shares | [1] | $ 0.15 | ||||
Expired - Compensation Options | shares | (47,000) | (200,000) | (235,500) | |||
Weighted Average exercise price, Compensation Options Expired | $ / shares | $ 10 | 0.60 | $ 0.50 | |||
Number of stock options, ending | shares | 9,120,636 | 9,120,636 | 9,320,636 | |||
Weighted average exercise price ending balance | $ / shares | $ 0.51 | 0.51 | $ 0.51 | |||
Compensation Options [Member] | ||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
Number of stock options, beginning | shares | 3,590,907 | 5,470,799 | 3,590,907 | |||
Weighted average exercise price beginning balance | $ / shares | $ 0.35 | 0.34 | $ 0.35 | |||
Issued - Compensation Options | shares | 2,070,258 | 1,879,892 | ||||
Weighted Average exercise price, Compensation Options Issued | $ / shares | 0.15 | $ 0.30 | ||||
Expired - Compensation Options | shares | (3,239,907) | |||||
Weighted Average exercise price, Compensation Options Expired | $ / shares | 0.35 | |||||
Number of stock options, ending | shares | 4,301,150 | 4,301,150 | 5,470,799 | |||
Weighted average exercise price ending balance | $ / shares | $ 0.24 | $ 0.24 | $ 0.34 | |||
April Two Thousand Twenty Two [Member] | ||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
Options grant fair value | $ | $ 264,435 | |||||
[1]On August 22, 2022, the Company granted 300,000 400,000 |
Schedule of Estimated Using Bla
Schedule of Estimated Using Black-Scholes Valuation Model for Fair Value of Broker Options (Details) - 9 months ended Sep. 30, 2023 | USD ($) | $ / shares |
March 2023 [Member] | ||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Options grant fair value | $ | $ 111,971 | |
April Two Thousand Twenty Two [Member] | ||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Risk free interest rate | 2.34% | |
Dividend yield | 0% | |
Volatility | 120% | |
Stock price | $ 0.30 | |
Weighted average life | 2 years | |
March 2023 [Member] | ||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Risk free interest rate | 3.40% | |
Dividend yield | 0% | |
Volatility | 120% | |
Stock price | $ 0.11 | |
Weighted average life | 3 years |
Schedule of Broker Exercise Pri
Schedule of Broker Exercise Prices (Details) | Sep. 30, 2023 $ / shares shares | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Number of warrants exercisable | 145,061,976 | |
Broker Options [Member] | ||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Number of broker options | 4,301,150 | |
Number of warrants exercisable | 444,484 | |
February 16, 2024 [Member] | ||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Expiry date | Feb. 16, 2024 | [1] |
Exercise price | $ / shares | $ 0.40 | [1] |
Number of broker options | 351,000 | [1] |
Number of warrants exercisable | 68,078 | [2] |
April 1, 2024 [Member] | ||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Expiry date | Apr. 01, 2024 | [2] |
Exercise price | $ / shares | $ 0.30 | [2] |
Number of broker options | 1,879,892 | [2] |
Number of warrants exercisable | 264,435 | [2] |
March 27, 2024 [Member] | ||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Expiry date | Mar. 27, 2026 | [3] |
Exercise price | $ / shares | $ 0.15 | [3] |
Number of broker options | 2,070,258 | [3] |
Number of warrants exercisable | 111,971 | [3] |
[1]Exercisable into one February 2021 Unit[2]Exercisable into one April 2022 Unit[3]Exercisable into one March 2023 Unit |
Schedule of Stock Options (Deta
Schedule of Stock Options (Details) - $ / shares | 4 Months Ended | 9 Months Ended | 12 Months Ended | |
May 01, 2022 | Sep. 30, 2023 | Dec. 31, 2022 | ||
Equity [Abstract] | ||||
Number of stock options, beginning | 9,053,136 | 9,320,636 | 9,053,136 | |
Weighted average exercise price beginning balance | $ 0.58 | $ 0.51 | $ 0.58 | |
Number of stock options, Granted | [1] | 700,000 | ||
Weighted average exercise price, Granted | [1] | $ 0.15 | ||
Number of stock options, Expired | (47,000) | (200,000) | (235,500) | |
Weighted average exercise price, Expired | $ 10 | $ 0.60 | $ 0.50 | |
Number of stock options, Forfeited | (150,000) | |||
Weighted average exercise price, Forfeited | $ 0.15 | |||
Number of stock options, ending | 9,120,636 | 9,320,636 | ||
Weighted average exercise price ending balance | $ 0.51 | $ 0.51 | ||
[1]On August 22, 2022, the Company granted 300,000 400,000 |
Schedule of Actual Stock Option
Schedule of Actual Stock Options Issued and Outstanding (Details) | 9 Months Ended | ||
Sep. 30, 2023 USD ($) $ / shares shares | Dec. 31, 2022 shares | Dec. 31, 2021 shares | |
Subsidiary, Sale of Stock [Line Items] | |||
Number of stock options outstanding | 9,120,636 | 9,320,636 | 9,053,136 |
Number of options vested (exercisable) | 7,431,222 | ||
Grant date fair value | $ | $ 2,227,898 | ||
Stock Options One [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Exercise price | $ / shares | $ 0.60 | ||
Remaining contractual life (years) | 1 year 25 days | ||
Number of stock options outstanding | 1,575,000 | ||
Number of options vested (exercisable) | 1,575,000 | ||
Grant date fair value | $ | $ 435,069 | ||
Stock Options Two [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Exercise price | $ / shares | $ 0.55 | ||
Remaining contractual life (years) | 1 year 6 months 21 days | ||
Number of stock options outstanding | 5,957,659 | ||
Number of options vested (exercisable) | 4,468,245 | ||
Grant date fair value | $ | $ 1,536,764 | ||
Stock Options Three [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Exercise price | $ / shares | $ 0.335 | ||
Remaining contractual life (years) | 2 years 4 months 20 days | ||
Number of stock options outstanding | 1,037,977 | ||
Number of options vested (exercisable) | 1,037,977 | ||
Grant date fair value | $ | $ 204,213 | ||
Stock Options Four [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Exercise price | $ / shares | $ 0.15 | ||
Remaining contractual life (years) | 1 month 24 days | ||
Number of stock options outstanding | 150,000 | ||
Number of options vested (exercisable) | 150,000 | ||
Grant date fair value | $ | $ 14,465 | ||
Stock Options Five [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Exercise price | $ / shares | $ 0.15 | ||
Remaining contractual life (years) | 4 years 1 month 24 days | ||
Number of stock options outstanding | 400,000 | ||
Number of options vested (exercisable) | 200,000 | ||
Grant date fair value | $ | $ 37,387 |
Capital Stock, Warrants and S_3
Capital Stock, Warrants and Stock Options (Details Narrative) | 1 Months Ended | 3 Months Ended | 9 Months Ended | |||||||||||||||||||
Mar. 27, 2023 shares | Nov. 23, 2022 shares | Aug. 22, 2022 shares | May 31, 2022 CAD ($) $ / shares shares | May 31, 2022 CAD ($) $ / shares shares | Mar. 31, 2023 USD ($) $ / shares shares | Mar. 31, 2023 CAD ($) shares | Jul. 31, 2022 shares | Jun. 30, 2022 $ / shares shares | Apr. 30, 2022 USD ($) shares | Apr. 30, 2022 CAD ($) shares | Sep. 30, 2023 USD ($) $ / shares shares | Sep. 30, 2022 USD ($) | Sep. 30, 2023 USD ($) $ / shares shares | Sep. 30, 2022 USD ($) | Sep. 30, 2023 $ / shares | Mar. 31, 2023 $ / shares | Dec. 31, 2022 USD ($) $ / shares shares | Dec. 31, 2022 $ / shares | May 13, 2022 $ / shares shares | Mar. 31, 2022 $ / shares | Feb. 28, 2022 $ / shares | |
Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||
Common stock, shares authorized | 1,500,000,000 | 1,500,000,000 | 1,500,000,000 | |||||||||||||||||||
Common stock, par value | $ / shares | $ 0.000001 | $ 0.000001 | $ 0.000001 | |||||||||||||||||||
Preferred stock, shares authorized | 10,000,000 | 10,000,000 | 10,000,000 | |||||||||||||||||||
Preferred stock, par value | $ / shares | $ 0.000001 | $ 0.000001 | $ 0.000001 | |||||||||||||||||||
Proceeds from issuance of private placement | $ 9,384,622 | $ 11,796,297 | ||||||||||||||||||||
Issuance of common stock, shares | 1,315,856 | 1,315,856 | ||||||||||||||||||||
Issue price | $ / shares | $ 0.30 | |||||||||||||||||||||
Warrants issued | 145,061,976 | 145,061,976 | ||||||||||||||||||||
Proceeds from warrant exercise | $ | $ 837,459 | |||||||||||||||||||||
Gross proceeds | $ | 3,661,822 | |||||||||||||||||||||
Gross proceeds, received in cash | $ | $ 28,360,495 | 28,360,495 | $ 708,105 | |||||||||||||||||||
Stock options granted | 400,000 | 300,000 | ||||||||||||||||||||
Share-Based Payment Arrangement [Member] | ||||||||||||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||
Options grant fair value | $ | 27,725 | $ 72,066 | 120,865 | $ 241,060 | ||||||||||||||||||
Contractors [Member] | ||||||||||||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||
Issuance of common stock, shares | 1,218,000 | |||||||||||||||||||||
Exercise price | $ / shares | $ 0.37 | |||||||||||||||||||||
Teck Rosources Limited [Member] | ||||||||||||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||
Issuance of common stock, shares | 10,416,667 | |||||||||||||||||||||
Issue price | $ / shares | $ 0.245 | $ 0.245 | ||||||||||||||||||||
Exercise price | $ / shares | 0.37 | 0.37 | ||||||||||||||||||||
Teck Resources Limited [Member] | ||||||||||||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||
Exercise price | $ / shares | $ 0.11 | $ 0.37 | ||||||||||||||||||||
Warrants issued | 10,416,667 | |||||||||||||||||||||
Warrants expired | Mar. 31, 2023 | |||||||||||||||||||||
Gain on warrant extinguishment | $ | $ 214,714 | |||||||||||||||||||||
Warrant exercised | 10,416,667 | 10,416,667 | ||||||||||||||||||||
Proceeds from warrant exercise | $ 837,460 | $ 1,145,834 | ||||||||||||||||||||
Derivative liability | $ | $ 400,152 | |||||||||||||||||||||
Volatility rate | 120% | 120% | ||||||||||||||||||||
Stock price | $ / shares | $ 0.11 | |||||||||||||||||||||
Interest rate | 3.42% | 3.42% | ||||||||||||||||||||
Interest rate | 4.06% | 4.06% | ||||||||||||||||||||
Dividend rate | 0% | 0% | ||||||||||||||||||||
Warrant [Member] | ||||||||||||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||
Warrant exercised | 10,416,667 | |||||||||||||||||||||
Common Stock [Member] | ||||||||||||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||
Issuance of common stock, shares | 1,975,482 | |||||||||||||||||||||
Stock issued during period shares conversion of units | 51,633,727 | |||||||||||||||||||||
March 2023 Special Warrants Issuance [Member] | ||||||||||||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||
Stock price | $ / shares | $ 0.15 | $ 0.11 | ||||||||||||||||||||
Private Placement [Member] | Warrant [Member] | ||||||||||||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||
Sale of stock of number of shares issued | 37,849,325 | 37,849,325 | ||||||||||||||||||||
Issuance of common stock, shares | 4,809,160 | 4,809,160 | ||||||||||||||||||||
Issue price | $ / shares | 0.30 | 0.30 | $ 0.30 | |||||||||||||||||||
Exercise price | $ / shares | $ 0.37 | $ 0.37 | $ 0.37 | |||||||||||||||||||
Cash commission | $ | $ 563,968 | $ 563,968 | ||||||||||||||||||||
Compensation options exercisable to acquire shares | 1,879,892 | |||||||||||||||||||||
Non-Brokered Private Placement [Member] | Warrant [Member] | ||||||||||||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||
Sale of stock of number of shares issued | 1,471,664 | 1,471,664 | ||||||||||||||||||||
Issuance of common stock, shares | 1,471,664 | |||||||||||||||||||||
Issue price | $ / shares | $ 0.30 | $ 0.30 | ||||||||||||||||||||
Exercise price | $ / shares | $ 0.37 | $ 0.37 | ||||||||||||||||||||
Brokered Private Placement [Member] | March 2023 Special Warrants Issuance [Member] | ||||||||||||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||
Issue price | $ / shares | $ 0.12 | |||||||||||||||||||||
Warrants issued | 51,633,727 | |||||||||||||||||||||
Gross proceeds | $ 4,536,020 | $ 6,196,047 | ||||||||||||||||||||
Gross proceeds, received in cash | $ | 3,661,822 | |||||||||||||||||||||
Settlement of accounts payable, accrued liabilities | $ | $ 874,198 | |||||||||||||||||||||
Warrants description | Each March 2023 Unit consists of one share of Common Share of the Company (each, a “Unit Share”) and one common stock purchase warrant of the Company (each, a “Warrant”). Each whole Warrant entitles the holder thereof to acquire one Common Share of the Company (a “Warrant Share”, and together with the Unit Shares, the “Underlying Shares”) at an exercise price of C$0.15 per Warrant Share until March 27, 2026, subject to adjustment in certain events. In the event that the Registration Statement has not been declared effective by the SEC on or before 5:00 p.m. (EST) on July 27, 2023, each unexercised Special Warrant will be deemed to be exercised on the Automatic Exercise Date into one penalty unit of the Company (each, a “Penalty Unit”), with each Penalty Unit being comprised of 1.2 Unit Shares and 1.2 Warrants. Notice of such effectiveness was received on July 11, 2023, eliminating the potential for issuance of the Penalty Units. | Each March 2023 Unit consists of one share of Common Share of the Company (each, a “Unit Share”) and one common stock purchase warrant of the Company (each, a “Warrant”). Each whole Warrant entitles the holder thereof to acquire one Common Share of the Company (a “Warrant Share”, and together with the Unit Shares, the “Underlying Shares”) at an exercise price of C$0.15 per Warrant Share until March 27, 2026, subject to adjustment in certain events. In the event that the Registration Statement has not been declared effective by the SEC on or before 5:00 p.m. (EST) on July 27, 2023, each unexercised Special Warrant will be deemed to be exercised on the Automatic Exercise Date into one penalty unit of the Company (each, a “Penalty Unit”), with each Penalty Unit being comprised of 1.2 Unit Shares and 1.2 Warrants. Notice of such effectiveness was received on July 11, 2023, eliminating the potential for issuance of the Penalty Units. | ||||||||||||||||||||
Compensation Options [Member] | Warrant [Member] | ||||||||||||||||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||
Payments of Stock Issuance Costs | $ | $ 846,661 | |||||||||||||||||||||
Stock options granted | 2,070,258 | |||||||||||||||||||||
Exercise price | $ / shares | $ 0.12 |
Schedule of Restricted Share Un
Schedule of Restricted Share Units (Details) | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||
Jul. 04, 2023 shares | Jun. 04, 2023 shares | Jun. 01, 2023 shares | Sep. 29, 2022 shares | Jun. 30, 2022 shares | Apr. 29, 2022 shares | Jan. 10, 2022 shares | Jun. 30, 2022 USD ($) shares | Sep. 30, 2023 USD ($) shares | Sep. 30, 2023 $ / shares | Dec. 31, 2022 USD ($) shares | Dec. 31, 2022 $ / shares | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||||||
Number of shares, Unvested, Beginning balance | 576,000 | 4,822,741 | 576,000 | |||||||||
Weighted average grant date fair value per share, Unvested, Beginning balance | $ / shares | $ 0.22 | $ 0.62 | ||||||||||
Share based payment award, grants in period | 10,844,993 | 6,620,641 | ||||||||||
Weighted average grant date fair value per share, Granted | $ / shares | 0.23 | 0.17 | ||||||||||
Number of shares, Vested | (5,767,218) | (2,373,900) | ||||||||||
Weighted average grant date fair value per share, Vested | $ / shares | 0.24 | 0.18 | ||||||||||
Number of shares, Unvested, ending balance | 9,900,516 | 4,822,741 | ||||||||||
Weighted average grant date fair value per share, Unvested, Ending balance | $ / shares | $ 0.22 | $ 0.22 | ||||||||||
Consultant [Member] | Restricted Stock Units (RSUs) [Member] | ||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||||||
Share based payment award, grants in period | 42,000 | 15,000 | 500,000 | |||||||||
Stock based compensation | $ | $ 122,249 | $ 7,825 | $ 2,328 | |||||||||
Consultant One [Member] | Restricted Stock Units (RSUs) [Member] | ||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||||||
Share based payment award, grants in period | 76,750 | |||||||||||
Stock based compensation | $ | $ 16,800 | |||||||||||
Two Consultants [Member] | Restricted Stock Units (RSUs) [Member] | ||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||||||
Share based payment award, grants in period | 33,000 | |||||||||||
Stock based compensation | $ | 2,889 | |||||||||||
Executives [Member] | Restricted Stock Units (RSUs) [Member] | ||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||||||
Share based payment award, grants in period | 4,067,637 | |||||||||||
Stock based compensation | $ | 322,905 | |||||||||||
Executives One [Member] | Restricted Stock Units (RSUs) [Member] | ||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||||||
Share based payment award, grants in period | 6,735,356 | |||||||||||
Stock based compensation | $ | $ 214,897 |
Restricted Share Units (Details
Restricted Share Units (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Restricted Stock Units (RSUs) [Member] | ||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||
Options grant fair value | $ 271,021 | $ 14,585 | $ 865,745 | $ 53,444 |
Schedule of Deferred Share Unit
Schedule of Deferred Share Units (Details) - $ / shares | 9 Months Ended | 12 Months Ended | |||
Sep. 30, 2023 | Dec. 31, 2022 | ||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||
Number of shares, Unvested, Beginning balance | 4,822,741 | 576,000 | |||
Weighted average grant date fair value per share, Unvested, Beginning balance | $ 0.22 | $ 0.62 | |||
Number of shares, Vested | (5,767,218) | (2,373,900) | |||
Weighted average grant date fair value per share, Vested | $ 0.24 | $ 0.18 | |||
Number of shares, Granted | 10,844,993 | 6,620,641 | |||
Weighted average grant date fair value per share, Granted | $ 0.23 | $ 0.17 | |||
Number of shares, Unvested, ending balance | 9,900,516 | 4,822,741 | |||
Weighted average grant date fair value per share, Unvested, Ending balance | $ 0.22 | $ 0.22 | |||
Deferred Share Unit [Member] | |||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||
Number of shares, Unvested, Beginning balance | 2,710,000 | 5,625,000 | |||
Weighted average grant date fair value per share, Unvested, Beginning balance | $ 0.97 | $ 1.03 | |||
Number of shares, Vested | (3,071,826) | [1],[2] | (3,125,000) | [3] | |
Weighted average grant date fair value per share, Vested | $ 0.55 | [1],[2] | $ 1.03 | [3] | |
Number of shares, Granted | [4],[5] | 1,857,280 | |||
Weighted average grant date fair value per share, Granted | [4],[5] | $ 0.23 | |||
Number of shares, Unvested, ending balance | 1,495,454 | 2,710,000 | |||
Weighted average grant date fair value per share, Unvested, Ending balance | $ 0.90 | $ 0.97 | |||
[1]On April 21, 2023, 1,250,000 210,000 625,000 2,500,000 750,000 375,000 0.30 1,611,826 245,454 |
Schedule of Deferred Share Un_2
Schedule of Deferred Share Units (Details) (Parenthetical) - CAD ($) | 1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||
Jul. 06, 2023 | Jul. 04, 2023 | Jul. 01, 2023 | Apr. 21, 2023 | Apr. 30, 2022 | Mar. 31, 2022 | Jun. 30, 2022 | Sep. 30, 2023 | Dec. 31, 2022 | |||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||||||||
Number of shares, vested | 5,767,218 | 2,373,900 | |||||||||
Shares issued, shares | 1,315,856 | ||||||||||
Shares issued price per share | $ 0.30 | ||||||||||
Deferred Share Unit [Member] | |||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||||||||
Director redeemed | 2,500,000 | ||||||||||
Shares issued | $ 750,000 | ||||||||||
April 2022 Special Warrant [Member] | |||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||||||||
Shares issued, shares | 375,000 | ||||||||||
Deferred Share Unit [Member] | |||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||||||||
Number of shares, vested | 3,071,826 | [1],[2] | 3,125,000 | [3] | |||||||
Deferred Share Unit [Member] | Director [Member] | |||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||||||||
Number of shares, vested | 245,454 | 1,611,826 | 210,000 | 1,250,000 | 625,000 | ||||||
[1]On April 21, 2023, 1,250,000 210,000 625,000 2,500,000 750,000 375,000 0.30 |
Deferred Share Units (Details N
Deferred Share Units (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Deferred Share Unit [Member] | ||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||
Options grant fair value | $ 141,969 | $ 188,194 | $ 145,355 | $ 1,083,610 |
Commitments and Contingencies (
Commitments and Contingencies (Details Narrative) | 9 Months Ended |
Sep. 30, 2023 USD ($) | |
Commitments and Contingencies Disclosure [Abstract] | |
Monthly payments | $ 10,000 |
Deferred tax liability (Details
Deferred tax liability (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Tax Disclosure [Abstract] | ||||
Income tax expense benefit | $ 900,000 | $ 0 | $ 2,610,000 | $ 0 |
Income tax rate | 52% | 0% | ||
Deferred tax assets | $ 35,800,000 | $ 35,800,000 |
Schedule of Related Party Trans
Schedule of Related Party Transactions (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Related Party Transactions [Abstract] | ||||
Consulting fees & wages | $ 225,061 | $ 248,472 | $ 797,978 | $ 1,832,323 |
Related party transactions (Det
Related party transactions (Details Narrative) - USD ($) | Sep. 30, 2023 | Sep. 30, 2022 |
Key Management Personnel [Member] | ||
Related Party Transaction [Line Items] | ||
Accounts payable and accrued liabilities | $ 15,000 |
Subsequent Events (Details Narr
Subsequent Events (Details Narrative) | 3 Months Ended |
Sep. 30, 2023 USD ($) | |
Subsequent Events [Abstract] | |
Debt instrument interest payment | $ 5,175,000 |